Anxiety (asthma-related co-morbidities)

PULM_ANXIETY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_PHOBANX F5_GAD F5_PANIC F5_ANXIETY F5_OCD	37517
6. Filter based on genotype QC (FinnGen only)	37517

Control definitions (FinnGen only)

Control exclude: PULM_PSYCH_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	PULM_ANXIETY
CONTROL_EXCLUDE	PULM_PSYCH_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_PHOBANX\|F5_GAD\|F5_PANIC\|F5_ANXIETY\|F5_OCD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anxiety (asthma-related co-morbidities) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	37517	26297	11220
Unadjusted period prevalence (%)	7.76	8.96	4.95
Median age at first event (years)	34.83	33.90	37.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25429: Matched controls
221676

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F41.8

ICD-10 Finland

Other specified anxiety disorders

18.5

323.0

1930

982

N05CD07

ATC

temazepam; oral

6.7

323.0

4123

6210

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

129.3

323.0

1376

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

158.3

323.0

551

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

30.6

323.0

9051

3931

N03AE01

ATC

clonazepam; systemic

8.5

323.0

2817

3183

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

158.3

323.0

3843

249

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

267.9

323.0

1139

P99

ICPC

Psychological disorders other

22.3

323.0

1530

635

N05CF01

ATC

zopiclone; oral

4.0

323.0

10345

32524

N05AC02

ATC

thioridazine; oral

21.8

323.0

782

322

N06AX21

ATC

duloxetine; oral

6.7

323.0

5031

7857

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

66.4

323.0

4813

776

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1512.4

323.0

970

F32.8

ICD-10 Finland

Other depressive episodes

27.1

323.0

749

248

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

19.4

323.0

716

330

F90.0

ICD-10 Finland

Disturbance of activity and attention

9.0

323.0

1305

1329

R02

ICPC

Shortness of breath/dyspnoea

2.7

323.0

2782

9735

N06AX22

ATC

agomelatine; oral

18.8

323.0

1251

608

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

18.5

323.0

1556

778

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

49.5

323.0

3240

652

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

141.9

323.0

542

P76

ICPC

Depressive disorder

12.9

323.0

3404

2627

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

1676.4

323.0

361

N05AA01

ATC

chlorpromazine; systemic, rectal

89.9

323.0

604

V03AA01

ATC

15.7

323.0

587

333

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

54.5

323.0

2350

413

N05AX12

ATC

aripiprazole; systemic

88.6

323.0

2717

299

T36

ICD-10 Finland

Poisoning by systemic antibiotics

41.3

323.0

2956

704

N05AN01

ATC

lithium; oral

36.9

323.0

1394

348

K02.1

ICD-10 Finland

Caries of dentine

1.8

323.0

14931

97726

F31

ICD-10 Finland

Bipolar affective disorder

23.8

323.0

604

226

N05BA02

ATC

chlordiazepoxide; systemic

18.0

323.0

1076

544

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

323.0

1042

S06.0

ICD-10 Finland

Concussion

2.7

323.0

2625

9131

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

41.4

323.0

900

196

N06AB10

ATC

escitalopram; oral

7.9

323.0

10508

18190

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

323.0

4302

19291

N06AB03

ATC

fluoxetine; oral

8.5

323.0

6360

8329

F39

ICD-10 Finland

Unspecified mood [affective] disorder

25.7

323.0

1004

354

188

Kela drug reimbursment

Psychosis requiring demanding treatment

689.9

323.0

467

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

9667

56678

F21

ICD-10 Finland

Schizotypal disorder

1122.9

323.0

381

P29

ICPC

Psychological sympt/compl other

9.9

323.0

2842

2794

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

74.2

323.0

3239

434

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

23.0

323.0

2158

888

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

208.8

323.0

608

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

41.1

323.0

1768

402

R74

ICPC

Upper respiratory infection acute

1.9

323.0

7676

41701

F41.3

ICD-10 Finland

Other mixed anxiety disorders

29.6

323.0

1049

322

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

32.2

323.0

1071

302

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

45.1

323.0

1237

251

A01

ICPC

Pain general/multiple sites

3.3

323.0

2004

5628

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

8668

47516

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

18.7

323.0

679

324

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

323.0

2709

7935

N06AA04

ATC

clomipramine; systemic

17.9

323.0

1067

540

SPAT1307

SPAT

Psychosocial counselling and guidance

6.4

323.0

2364

3472

F32.1

ICD-10 Finland

Moderate depressive episode

10.2

323.0

2550

2384

N06BA04

ATC

methylphenidate; oral

8.8

323.0

1060

1086

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

323.0

5691

27485

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

323.0

9833

47980

A06AD11

ATC

lactulose; oral

3.1

323.0

3042

9387

N05AB01

ATC

dixyrazine; systemic

27.2

323.0

562

184

F60.9

ICD-10 Finland

Personality disorder, unspecified

143.8

323.0

1135

R51.80

ICD-10 Finland

Headache

2.6

323.0

4345

16230

F33.8

ICD-10 Finland

Other recurrent depressive disorders

58.3

323.0

467

N06AX26

ATC

vortioxetine; oral

10.6

323.0

3071

2824

N05AH03

ATC

olanzapine; systemic

64.5

323.0

4322

701

N05AX08

ATC

risperidone; systemic

24.9

323.0

3954

1625

N05AH04

ATC

quetiapine; oral

19.6

323.0

11099

8410

F10.25

ICD-10 Finland

Alcohol dependence continuous use

108.7

323.0

844

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

140.4

323.0

705

R06.0

ICD-10 Finland

Dyspnoea

2.2

323.0

5629

25169

N03AX09

ATC

lamotrigine; oral

16.1

323.0

2939

1785

N04AA02

ATC

biperiden; systemic

51.8

323.0

857

149

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

323.0

344

F43.1

ICD-10 Finland

Post-traumatic stress disorder

14.6

323.0

1262

789

F40.2

ICD-10 Finland

Specific (isolated) phobias

46.3

323.0

628

121

N05AH02

ATC

clozapine; systemic

574.5

323.0

954

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

45.4

323.0

1534

313

R21

ICPC

Throat symptom/complaint

2.0

323.0

5267

25232

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

323.0

5543

26467

F40.1

ICD-10 Finland

Social phobias

78.1

323.0

2613

325

P06

ICPC

Sleep disturbance

3.6

323.0

3226

8500

P16

ICPC

Acute alcohol abuse

17.4

323.0

678

348

N06AA12

ATC

doxepin; systemic

8.3

323.0

2126

2401

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

52.8

323.0

423

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

163.7

323.0

1352

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2781.1

323.0

640

N05BA12

ATC

alprazolam; oral

8.4

323.0

5749

7439

N05AA02

ATC

levomepromazine; systemic

49.7

323.0

2551

496

P72

ICPC

Schizophrenia

166.1

323.0

794

N05AB03

ATC

perphenazine; systemic, rectal

50.4

323.0

2105

396

F51.0

ICD-10 Finland

Nonorganic insomnia

3.8

323.0

4961

13202

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

323.0

3421

8185

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

54.1

323.0

1043

175

N05BE01

ATC

buspirone; oral

29.7

323.0

2144

686

N05AF03

ATC

chlorprothixene; systemic

80.5

323.0

1723

200

N05BA04

ATC

oxazepam; oral

9.3

323.0

12505

20958

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

687.5

323.0

389

N05AD01

ATC

haloperidol; systemic

15.0

323.0

1033

625

N03AX12

ATC

gabapentin; oral

2.7

323.0

4243

15209

N06AX11

ATC

mirtazapine; oral

6.8

323.0

13614

32002

SPAT1240

SPAT

Therapeutic discussion

6.4

323.0

4798

7769

N07BB01

ATC

disulfiram; oral

16.0

323.0

2381

1426

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

41.8

323.0

827

178

N06AX05

ATC

trazodone; oral

17.4

323.0

1419

751

N05AE04

ATC

ziprasidone; systemic

117.5

323.0

385

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

51.2

323.0

961

170

F34.1

ICD-10 Finland

Dysthymia

33.9

323.0

2538

723

SPAT1243

SPAT

Psychiatric/psychological examination

8.0

323.0

1082

1228

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

87.5

323.0

502

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

40.8

323.0

469

102

P15

ICPC

Chronic alcohol abuse

18.0

323.0

1279

650

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.5

323.0

1457

2927

F10.09

ICD-10 Finland

Alcohol intoxication UNS

196.2

323.0

870

Z71.8

ICD-10 Finland

Other specified counselling

2.3

323.0

6533

29097

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2571.2

323.0

594

G44.2

ICD-10 Finland

Tension-type headache

2.5

323.0

3782

14643

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

323.0

440

F41.09

ICD-10 Finland

UNS Panic Syndrome

49.6

323.0

3084

615

N05CF02

ATC

zolpidem; oral

3.2

323.0

5946

19432

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

323.0

6904

35128

N06AB08

ATC

fluvoxamine; oral

11.8

323.0

1380

1072

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

123.5

323.0

823

N03AX16

ATC

pregabalin; oral

3.0

323.0

7085

25458

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

95.0

323.0

1822

180

IGV01

NOMESCO Finland

Psychiatric network contact

97.1

323.0

427

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

75.8

323.0

994

119

N05AL01

ATC

sulpiride; systemic

20.9

323.0

682

292

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

137.0

323.0

748

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

323.0

7638

39711

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

17465

120972

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

557.1

323.0

625

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

323.0

9005

52860

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

92.3

323.0

4880

570

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

85.3

323.0

1476

160

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

323.0

3121

10931

N06AA09

ATC

amitriptyline; systemic

3.9

323.0

3014

7384

F10.20

ICD-10 Finland

Alcohol dependence currently independent

133.7

323.0

1269

R53

ICD-10 Finland

Malaise and fatigue

3.0

323.0

5796

20075

R42

ICD-10 Finland

Dizziness and giddiness

2.3

323.0

4982

21102

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

13.2

323.0

5632

4668

F99

ICD-10 Finland

Mental disorder, not otherwise specified

23.8

323.0

1235

475

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

62.7

323.0

763

109

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

105.2

323.0

897

N06AX03

ATC

mianserin; oral

12.1

323.0

2271

1777

N03AG01

ATC

valproic acid; systemic, rectal

11.7

323.0

3202

2691

N05AF01

ATC

flupentixol; systemic

21.4

323.0

813

341

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

6118.3

323.0

1349

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

44.1

323.0

5606

1412

A04

ICPC

Weakness/tiredness general

3.2

323.0

3370

10086

D11

ICPC

Diarrhoea

2.6

323.0

3173

11591

N06AX12

ATC

bupropion; oral

15.4

323.0

3952

2616

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

44.4

323.0

10209

3297

IBA03

NOMESCO Finland

Psychotherapy evaluation

81.9

323.0

443

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.5

323.0

2451

6556

N06AX16

ATC

venlafaxine; oral

12.2

323.0

8569

8847

R03AC02

ATC

salbutamol; inhalant

1.7

323.0

12980

84288

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

44.1

323.0

1524

320

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.5

323.0

1815

4827

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

323.0

6146

29107

P74

ICPC

Anxiety disorder/anxiety state

17.3

323.0

2381

1315

N06AG02

ATC

moclobemide; oral

10.6

323.0

2094

1852

N01

ICPC

Headache

2.8

323.0

2808

9547

F41.00

ICD-10 Finland

Moderate panic disorder

214.2

323.0

2036

F32.9

ICD-10 Finland

Depressive episode, unspecified

33.6

323.0

8369

3193

EBA00

NOMESCO Finland

Extraction of tooth

1.9

323.0

8063

42863

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

323.0

18289

127115

F29

ICD-10 Finland

Unspecified nonorganic psychosis

365.1

323.0

2477

WX290

NOMESCO Finland

Other blockade of nerve

1.8

323.0

11950

73609

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

323.0

359

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

323.0

6451

31936

IGY99

NOMESCO Finland

Other psychiatric treatment contact

73.9

323.0

1165

144

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

323.0

496

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

16.8

323.0

1551

853

F22.0

ICD-10 Finland

Delusional disorder

280.8

323.0

654

IGY02

NOMESCO Finland

Psychiatric monitoring contact

72.7

323.0

1455

185

F60.5

ICD-10 Finland

Anankastic personality disorder

35.2

323.0

647

164

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

323.0

9836

57836

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

291.4

323.0

398

AA1AD

NOMESCO Finland

CT of head and brain

2.3

323.0

5048

21293

IEY01

NOMESCO Finland

Psychoeducation, individual

104.8

323.0

379

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

323.0

2299

6830

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

381.3

323.0

559

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

46.7

323.0

1694

338

SPAT1234

SPAT

Support of social functional capacity

5.6

323.0

1220

1986

N06AA06

ATC

trimipramine; systemic

10.1

323.0

1082

969

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

323.0

3564

14225

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

103.5

323.0

1296

115

M54.5

ICD-10 Finland

Low back pain

2.0

323.0

8660

45219

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

109.1

323.0

4505

437

C07AA05

ATC

propranolol; systemic

4.5

323.0

8189

21011

F32

ICD-10 Finland

Depressive episode

7.7

323.0

2254

2757

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

323.0

4068

16472

F33

ICD-10 Finland

Recurrent depressive disorder

14.1

323.0

893

572

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

94.3

323.0

1622

160

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

137.7

323.0

885

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

323.0

12465

78364

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.3

323.0

680

590

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

90.4

323.0

1704

176

F60.8

ICD-10 Finland

Other specific personality disorders

92.8

323.0

460

A02BC02

ATC

pantoprazole; systemic

1.9

323.0

15644

100546

L17

ICPC

Foot/toe symptom/complaint

2.0

323.0

5671

27547

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

325.1

323.0

515

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

84.4

323.0

1683

186

N05BA06

ATC

lorazepam; systemic, sublingual

13.1

323.0

2287

1658

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

323.0

459

N06AB04

ATC

citalopram; systemic

9.1

323.0

10968

17066

F41.01

ICD-10 Finland

Severe panic disorder

276.3

323.0

584

F31.8

ICD-10 Finland

Other bipolar affective disorders

39.8

323.0

1204

276

N06AB06

ATC

sertraline; oral

12.4

323.0

6794

6325

N05BA01

ATC

diazepam; systemic, rectal

7.4

323.0

6135

9186

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

323.0

742

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

323.0

14170

92231

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1403.9

323.0

911

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

127.9

323.0

616

N06AB05

ATC

paroxetine; oral

11.1

323.0

3906

3558

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

323.0

4127

17773

N05AF05

ATC

zuclopenthixol; systemic

186.3

323.0

379

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

276.3

323.0

409

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

51.7

323.0

811

141

F41.1

ICD-10 Finland

Generalized anxiety disorder

50.3

323.0

5394

1182

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

150.8

323.0

442

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

232.2

323.0

849

F10.24

ICD-10 Finland

Alcohol depence active use

96.8

323.0

744

F61.0

ICD-10 Finland

Mixed personality disorders

116.8

323.0

1490

118

P03

ICPC

Feeling depressed

7.9

323.0

4246

5513

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

113.4

323.0

460

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.9

323.0

939

1230

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

6.7

323.0

1984

2756

P01

ICPC

Feeling anxious/nervous/tense

8.9

323.0

5476

6655

SPAT1254

SPAT

Administration of medicine

2.7

323.0

3269

11502

L03

ICPC

Low back symptom/complaint

2.2

323.0

6051

28031

AA400

NOMESCO Finland

Electroconvulsive therapy

421.4

323.0

523

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

29.3

323.0

1517

478

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

322.7

2247

7240

C07AB07

ATC

bisoprolol; oral

1.7

321.9

8947

52754

SPAT1301

SPAT

No procedures

1.8

321.5

6785

36611

D01

ICPC

Abdominal pain/cramps general

2.6

321.1

2727

9899

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

114.3

317.1

362

L28

ICPC

Limited function/disability (L)

2.4

316.8

3041

11789

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

316.5

13240

87687

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

312.8

316

A02BC01

ATC

omeprazole; systemic

1.9

312.1

6049

31630

N05AD03

ATC

melperone; systemic

25.3

311.6

462

162

F61

ICD-10 Finland

Mixed and other personality disorders

108.5

310.3

356

L01

ICPC

Neck symptom/complaint

2.3

309.3

3404

14113

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

151.9

308.9

344

P98

ICPC

Psychosis NOS/other

145.1

308.7

345

B18.2

ICD-10 Finland

Chronic viral hepatitis C

13.9

307.7

562

360

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

29.4

307.5

438

132

R11

ICD-10 Finland

Nausea and vomiting

3.0

306.9

1979

6055

N02BE01

ATC

paracetamol; systemic, rectal

1.8

304.7

20523

154848

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

103.4

304.4

351

N03AF01

ATC

carbamazepine; oral, rectal

3.9

302.0

1383

3252

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

351.2

301.7

320

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

155.7

301.4

335

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

129.8

299.6

338

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

299.0

5407

27515

R05

ICPC

Cough

1.9

298.9

5168

25866

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

298.9

302

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

46.6

298.7

385

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

26.1

296.7

436

148

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

83.4

295.5

349

A28

ICPC

Limited function/disability NOS

2.6

291.7

2445

8783

P18

ICPC

Medication abuse

50.3

291.0

370

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

290.3

5962

31669

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

287.8

4066

18773

P27

ICPC

Fear of mental disorder

16.4

286.6

489

264

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

286.3

8775

52754

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

20.4

285.9

452

196

F60.7

ICD-10 Finland

Dependent personality disorder

134.1

283.6

319

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

283.0

286

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

146.8

283.0

316

L02

ICPC

Back symptom/complaint

2.6

281.8

2372

8532

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

4.6

281.0

1068

2103

A02BC05

ATC

esomeprazole; systemic

1.7

280.6

9405

57895

G47.3

ICD-10 Finland

Sleep apnoea

1.9

279.9

5002

25258

IER01

NOMESCO Finland

Psychoeducation, group

192.8

279.5

306

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

108.6

279.0

320

F41

ICD-10 Finland

Other anxiety disorders

8.5

278.2

653

687

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

221.4

277.3

301

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

277.1

280

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

45.8

276.9

358

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

276.7

2813

11176

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

276.5

16138

114770

N06AX18

ATC

reboxetine; oral

14.0

275.3

501

318

A02BC03

ATC

lansoprazole; oral

1.8

275.1

6472

35834

SPAT1310

SPAT

Counselling related to known health issue

1.7

272.7

6875

38870

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

79.5

272.7

324

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

75.1

269.9

323

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

146.5

267.8

299

M79.7

ICD-10 Finland

Fibromyalgia

4.4

267.6

1062

2182

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

173.4

267.6

295

N06AX17

ATC

milnacipran; oral

13.0

266.9

502

344

KMAK

NOMESCO Finland

1.6

266.8

13224

89785

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

266.7

4031

19063

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

265.0

1554

4435

A02BA02

ATC

ranitidine; systemic

2.0

264.1

4183

20136

P25

ICPC

Phase of life problem adult

3.7

263.2

1252

3034

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

262.5

1350

3488

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

262.2

265

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

8.7

262.0

605

619

M79.1

ICD-10 Finland

Myalgia

2.1

261.0

3235

14075

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

260.9

11357

74445

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

70.9

259.6

313

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

97.7

257.8

299

SPAT1263

SPAT

Sampling

1.6

257.6

9440

59121

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

255.2

5758

31324

P01AB01

ATC

metronidazole; oral, rectal

1.6

255.2

9346

58478

F43.29

ICD-10 Finland

Adaptation disorder UNS

5.7

254.8

789

1233

-1

NOMESCO Finland

1.6

254.2

8285

50225

P19

ICPC

Drug abuse

15.4

254.1

444

255

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.8

253.3

1834

6021

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

252.9

7633

45282

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

53.6

251.3

316

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

248.2

2897

12250

P28

ICPC

Limited function/disability (P)

31.6

248.2

347

N17

ICPC

Vertigo/dizziness

2.4

247.7

2283

8597

SPAT1260

SPAT

Consultation of another employee

2.0

246.7

3774

17878

R52.9

ICD-10 Finland

Pain, unspecified

2.5

246.5

2090

7520

F60.0

ICD-10 Finland

Paranoid personality disorder

197.4

246.1

269

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

150.3

245.0

273

F40.8

ICD-10 Finland

Other phobic anxiety disorders

51.4

244.1

309

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

58.9

243.1

301

Z72.1

ICD-10 Finland

Alcohol use

14.1

243.0

440

276

F20

ICD-10 Finland

Schizophrenia

2098.6

242.0

247

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

240.8

2414

9484

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

240.4

243

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

239.9

3941

19161

SPAT1283

SPAT

Restricted health certificate

1.8

239.2

4814

25148

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

1081.7

239.0

246

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.1

237.7

624

781

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

237.2

4885

25706

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.6

237.1

1166

2901

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

366.4

237.0

251

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

71.8

236.8

285

R52.2

ICD-10 Finland

Other chronic pain

4.2

235.7

974

2078

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

235.5

14325

100793

T74.1

ICD-10 Finland

Physical abuse

6.0

234.9

700

1042

SPAT1216

SPAT

Assessment of functional ability

2.2

234.1

2728

11506

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

233.1

2818

12083

F32.0

ICD-10 Finland

Mild depressive episode

5.4

232.9

756

1250

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

231.8

4109

20512

Z00.0

ICD-10 Finland

General medical examination

1.9

231.4

4018

19910

S29

ICPC

Skin symptom/complaint other

2.0

229.6

3497

16494

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

229.5

6083

34568

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

228.5

231

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

226.3

4621

24196

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

157.8

226.1

251

SPAT1265

SPAT

Breathalyser

14.8

225.7

401

240

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

1019.5

225.2

232

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

224.1

5867

33178

SPAT1312

SPAT

General health counselling

1.6

223.4

6877

40710

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011397) Hemoglobin [Presence] in Urine by Test strip

8840

46572

1.66

323.31

3.8

3.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8982

47535

1.65

323.01

1.8

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6720

33045

1.74

316.25

3.9

3.1

ng/l

249.5

553.4

4.89

4059

22284

(36660697) Celiac disease serology panel - Serum

4305

18454

1.95

314.12

1.2

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4084

17272

1.98

309.51

1.9

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

3010

11357

2.19

308.83

4.0

3.4

kpa

4.8

4.7

2.10

2891

11025

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4051

17103

1.98

308.45

1.8

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2017

3001

5.56

307.65

1.4

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

26925

154975

2.52

307.65

7.7

6.9

u/l

75.2

75.3

0.02

25455

146556

(3037467) Urinalysis macro (dipstick) panel - Urine

23963

147102

1.87

307.65

4.9

3.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

18692

103687

1.89

307.65

6.8

5.7

29.5

29.3

1.19

17453

97684

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11022

52985

1.93

307.65

1.4

1.3

u/ml

1.3

1.7

2.74

2751

15481

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18801

100333

2.01

307.65

3.3

2.7

ug/l

85.3

103.3

18.63

17538

94994

(3019550) Sodium [Moles/volume] in Serum or Plasma

32931

221778

3.31

307.65

17.1

11.3

mmol/l

139.4

139.7

95.22

32249

215899

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10145

39960

2.40

307.65

2.6

2.0

—

(3001604) Monocytes [#/volume] in Blood

19411

104558

2.02

307.65

6.7

5.7

e9/l

0.6

1.10

16771

92215

(3013650) Neutrophils [#/volume] in Blood by Automated count

21791

120900

2.09

307.65

10.7

8.0

e9/l

4.1

3.9

20.38

18926

106633

(3021589) Normoblasts [#/volume] in Blood

16500

94317

1.71

307.65

9.8

8.3

e9/l

0.0

2.48

13270

78088

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1092

220

40.34

307.65

11.7

9.1

mmol/l

0.6

0.53

1010

198

(3018095) Leukocytes [#/volume] in Urine

13371

67850

1.89

307.65

4.1

3.3

e6/l

64.7

79.1

1.69

9119

45797

(3033658) Prothrombin time (PT) actual/Normal

9815

49085

1.80

307.65

4.4

3.6

95.2

93.8

6.79

9493

47849

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5501

25268

1.85

307.65

2.4

g/l

2.5

2.4

10.65

5011

23676

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6451

30441

1.82

307.65

2.8

2.5

e6/l

1.2

1.1

0.27

3392

16826

(3026008) Bacteria identified in Urine by Culture

10623

53506

1.81

307.65

3.2

2.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10298

43996

2.19

307.65

2.4

2.1

mg/l

2.7

2.8

2.32

8819

38122

(3013826) Glucose [Moles/volume] in Serum or Plasma

20256

113657

1.94

307.65

5.4

4.1

mmol/l

6.4

6.5

6.50

18818

104147

(3030467) Casts [#/volume] in Urine by Automated count

10366

50329

1.88

307.65

3.3

2.8

e6/l

0.3

1.46

7739

36918

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5040

21576

1.98

307.65

2.6

2.8

umol/l

6.2

7.4

5.69

4112

18868

(3021387) Prolactin [Units/volume] in Serum or Plasma

3142

10160

2.58

307.65

1.7

1.6

mu/l

377.9

270.1

14.30

2768

9230

(40758558) Short blood count panel - Blood

10288

50300

1.86

307.65

7.6

6.4

—

(3044889) 12 lead EKG panel

22444

140820

1.70

307.65

3.6

3.0

—

(3015736) pH of Urine

14829

79797

1.80

307.65

3.7

2.9

6.1

5.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15586

77470

2.04

307.65

4.6

4.8

g/l

36.8

36.4

9.58

14394

72397

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15980

68320

2.53

307.65

2.1

1.7

pmol/l

98.1

98.5

0.54

8737

35883

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2864

8260

2.89

307.65

2.0

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

9551

45536

1.89

307.65

1.5

1.4

g/l

2.2

2.3

3.93

5366

29870

(3019309) Folate [Moles/volume] in Red Blood Cells

7546

24921

2.76

307.65

1.8

1.7

nmol/l

1121.0

1172.1

4.80

5925

19177

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11173

51569

2.03

307.65

2.5

1.9

u/l

224.7

188.8

1.43

10518

48694

(3023183) Ammonium ion [Moles/volume] in Plasma

1133

2452

3.73

307.65

2.6

2.9

umol/l

33.1

33.9

0.53

972

2118

(3028300) Cannabinoids [Presence] in Urine

5316

10656

4.45

307.65

3.2

1.3

—

(3012544) pH of Venous blood

3656

14469

2.11

307.65

4.6

4.1

7.4

0.09

(3020191) Ethanol [Moles/volume] in Serum or Plasma

823

771

8.59

307.65

1.9

1.1

promille

1.5

1.0

11.26

620

617

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11954

66902

1.62

307.65

3.9

2.8

ng/l

38.1

54.1

0.76

6631

36858

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6298

27356

1.99

307.65

3.5

3.6

mmol/l

0.8

4.20

5827

25754

(3015377) Calcium [Moles/volume] in Serum or Plasma

13557

58984

2.31

307.65

2.8

3.4

mmol/l

2.4

2.65

11960

52658

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16757

77371

2.34

307.65

6.0

5.7

mmol/l

1.2

0.11

15343

70537

(1001926) Buprenorphine [Presence] in Urine by Screen method

4734

7133

5.88

307.65

3.2

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3476

13437

2.15

307.65

7.2

7.5

mmol/l

1.4

1.3

4.45

3321

13033

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16554

83156

2.07

307.65

2.5

2.2

nmol/l

71.7

75.9

66.45

15258

76938

(3019198) Lymphocytes [#/volume] in Blood

19922

108921

2.00

307.65

6.7

5.6

e9/l

2.0

1.9

7.28

17560

97778

(3002582) Erythrocytes [#/volume] in Urine

11150

55551

1.85

307.65

3.5

2.9

e6/l

45.7

72.4

2.54

8498

41745

(3009466) Valproate [Moles/volume] in Serum or Plasma

1714

1123

12.59

307.65

5.7

3.5

umol/l

368.9

363.5

0.47

1512

961

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15206

67060

2.38

307.65

3.6

3.0

u/l

30.6

32.0

2.02

14374

64096

(3048689) Calprotectin [Mass/mass] in Stool

6656

29790

1.94

307.65

2.3

2.6

ug/g

106.2

129.9

7.23

5014

23911

(3026782) Osmolality of Urine

7586

34386

1.94

307.65

2.8

2.6

mosm/kgh2o

519.7

554.9

24.26

6469

29296

(3023511) Choriogonadotropin [Units/volume] in Urine

2346

6081

3.19

307.65

1.5

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

18222

99438

1.91

307.65

7.0

6.0

8.2

8.4

17.30

17062

94124

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6839

29439

2.03

307.65

2.6

3.0

mmol/l

2.4

21.13

5856

25922

(3017143) Hepatitis C virus Ab [Presence] in Serum

6932

30744

1.97

307.65

1.8

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1343

461

23.83

307.65

1.9

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5821

26043

1.91

307.65

2.0

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18238

86687

2.35

307.65

6.5

6.3

mmol/l

1.2

2.57

15739

73350

(3016879) Cocaine [Presence] in Urine

5134

9449

4.84

307.65

3.2

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32139

204735

3.47

307.65

6.1

4.2

mu/l

1.8

2.1

3.79

30454

191508

(3009508) Creatinine [Moles/volume] in Urine

11327

54616

1.93

307.65

3.6

3.1

mmol/l

8.0

8.1

1.36

9683

47096

(3021960) Folate [Moles/volume] in Serum or Plasma

9458

35142

2.53

307.65

1.6

1.4

nmol/l

20.1

20.5

2.15

8490

30545

(3002032) Base excess in Venous blood by calculation

3570

13917

2.14

307.65

4.6

4.1

mmol/l

1.8

0.22

2919

11452

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

30274

208996

1.95

307.65

13.4

9.7

ml/min/173m2

93.4

87.9

307.65

24726

171114

(3000850) Epithelial cells [#/volume] in Urine

7970

37647

1.86

307.65

2.7

2.4

e6/l

7.2

6.0

7.05

6961

32761

(3011288) Drugs identified in Urine by Screen method

4764

5253

8.10

307.65

4.3

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7654

35666

1.88

307.65

1.7

1.6

pmol/l

25769194.7

38999285.4

1.27

6504

30565

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

25952

157882

2.09

307.65

4.2

2.6

u/l

43.9

40.2

11.13

24597

150390

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8879

46417

1.68

307.65

2.0

1.8

mg/l

0.9

1.0

1.96

6327

34766

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6130

28558

1.84

307.65

3.0

2.6

e6/l

4.5

3.1

7.00

3078

15035

(3018418) pH of Serum or Plasma

11428

50270

2.17

307.65

3.7

4.1

7.4

1.25

1882

9805

(3022948) Iron [Moles/volume] in Serum or Plasma

5975

27816

1.83

307.65

2.4

umol/l

13.8

14.9

0.84

5527

26022

(3022096) Basophils/100 leukocytes in Blood

17618

95506

1.90

307.65

6.8

5.9

0.7

6.00

16410

89865

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

12875

66251

1.83

307.65

3.5

3.0

—

0.3

—

(3006315) Basophils [#/volume] in Blood

19485

104920

2.03

307.65

6.7

5.7

e9/l

0.0

0.12

16808

92439

(3027944) Amphetamines [Presence] in Urine

5121

10603

4.28

307.65

2.9

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3613

13412

2.25

307.65

2.5

2.3

u/l

5829.1

6263.3

0.31

1196

5758

(3006504) Eosinophils/100 leukocytes in Blood

18129

98875

1.91

307.65

6.7

5.8

2.7

2.9

18.32

16905

92950

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5034

21133

2.02

307.65

5.6

6.4

mmol/l

1.0

0.32

4721

19945

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6190

23191

2.34

307.65

2.4

1.9

—

(3018010) Neutrophils/100 leukocytes in Blood

18489

102187

1.89

307.65

6.6

5.6

56.3

56.4

0.02

17300

96672

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

18993

98315

2.12

307.65

5.8

umol/l

9.8

10.9

38.32

17797

93252

(3027008) Opiates [Presence] in Urine

5297

10641

4.44

307.65

3.1

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12686

59296

2.07

307.65

3.0

2.4

u/l

55.1

57.7

3.85

11658

55118

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

9429

35860

2.46

307.65

2.5

1.9

—

(4198724)

1029

327

25.51

307.65

2.5

2.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4714

16905

2.38

307.65

2.9

2.4

u/l

43.4

42.8

0.02

4042

14574

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

33664

243807

2.66

307.65

11.8

8.6

u/l

27.6

26.8

6.85

32818

236612

(3020564) Creatinine [Moles/volume] in Serum or Plasma

33446

241752

2.52

307.65

16.9

11.9

umol/l

71.3

73.3

31.60

33439

241619

(3019150) Specific gravity of Urine by Refractometry

9169

43460

1.89

307.65

4.1

3.4

kg/l

1.0

0.17

1055

6903

(3023368) Bacteria identified in Blood by Culture

8797

44150

1.76

307.65

4.6

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10184

55425

1.63

307.65

1.9

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

30787

209541

2.18

307.65

4.6

3.6

mmol/l

5.8

5.7

26.71

28709

195481

(3013707) Erythrocyte sedimentation rate by Westergren method

25741

158198

2.02

307.65

4.2

3.7

mm/h

10.1

0.12

24015

148419

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

32620

228915

2.49

307.65

16.2

10.6

mg/l

19.8

21.6

20.67

26098

174632

(3028707) Methadone [Presence] in Urine by Screen method

4021

1648

21.56

307.65

3.3

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11890

57385

1.95

307.65

2.3

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5217

17445

2.59

307.65

2.0

2.2

nmol/l

376.0

373.7

0.33

4735

16242

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

10259

24906

4.16

307.65

2.2

1.4

1.5

1.3

230.74

9185

22661

(36304419) Bacteria [Presence] in Urine

10271

50066

1.87

307.65

3.3

2.8

—

(3042517) Benzodiazepines panel - Urine

357

76.82

307.65

3.0

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

5304

10500

4.50

307.65

3.1

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

29546

171821

3.10

307.65

5.0

3.7

pmol/l

14.3

14.6

86.09

27522

158864

(3013115) Eosinophils [#/volume] in Blood

19985

108833

2.02

307.65

7.3

5.7

e9/l

0.2

3.82

17511

97344

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

611

369

13.26

307.65

3.1

1.3

umol/l

174.0

103.5

2.68

295

177

(42870588) Differential panel, method unspecified - Blood

13574

67905

1.93

307.65

6.2

6.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3592

13961

2.14

307.65

4.6

4.1

kpa

5.9

5.8

7.47

3467

13590

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4952

18313

2.31

307.65

2.2

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

32979

222703

3.31

307.65

17.1

11.4

mmol/l

3.9

94.85

32232

216325

(3031040) Bacteria [#/volume] in Urine by Automated count

23443

136630

2.03

307.65

5.3

3.7

e6/l

1431.7

1352.3

0.07

332

1672

(3035350) Ketones [Presence] in Urine by Test strip

17107

106037

1.52

305.97

4.0

3.1

estimate

0.0

0.73

3247

19527

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2217

7456

2.43

296.37

4.7

mmol/l

24.1

0.02

1994

6820

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1424

3805

3.03

296.24

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3455

13999

2.05

294.14

3.0

3.5

pmol/l

4.5

4.6

2.91

3014

12755

(3021601) Nitrite [Presence] in Urine by Test strip

17059

106540

1.50

287.25

5.3

4.3

estimate

0.0

0.03

3383

20147

(3009261) Glucose [Presence] in Urine by Test strip

17179

107533

1.50

285.39

4.0

3.2

estimate

0.0

0.98

3299

19598

(3032080) INR in Blood by Coagulation assay

11969

69459

1.54

283.93

6.9

inr

1.1

1.2

8.89

3728

21242

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

28024

195008

1.63

283.45

5.5

4.6

mmol/mol

38.2

38.5

5.22

26231

184028

(3000991) Gas panel - Venous blood

3258

13203

2.04

276.39

8.6

8.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

4887

22737

1.80

273.82

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4971

23250

1.80

273.68

2.5

22.6

23.9

7.84

4324

20128

(3002385) Erythrocyte distribution width [Ratio]

28079

196162

1.61

270.04

19.9

12.5

13.5

0.32

27646

192137

(3014576) Chloride [Moles/volume] in Serum or Plasma

4368

19781

1.84

266.61

7.6

7.2

mmol/l

104.2

104.7

9.05

4250

19397

(3019832) Treponema pallidum Ab [Presence] in Serum

6863

35388

1.66

265.04

1.9

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1188

3069

3.12

261.26

1.7

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3651

15738

1.92

258.93

2.5

2.4

g/l

0.2

1.32

3345

14872

(40768797) Stomach Pathology biopsy report

5423

26402

1.73

258.69

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2309

8494

2.22

250.20

1.7

1.6

—

(40761511) CBC panel - Blood by Automated count

33073

243268

2.03

243.80

14.7

9.7

—

(3037522) Nuclear Ab [Titer] in Serum

6109

31172

1.66

243.16

1.4

titre

477.1

556.4

2.49

1087

6242

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2519

9764

2.11

239.10

3.5

3.3

kpa

5.2

5.1

6.24

2351

9053

(3013512) EKG study

8858

49696

1.54

235.52

3.7

3.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2417

9275

2.13

235.31

3.4

3.3

mmol/l

1.5

0.22

1792

6685

(3009343) pH of Capillary blood

2484

9636

2.11

235.16

3.5

3.3

7.4

0.84

299

1259

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

590

1045

4.51

221.26

1.8

1.3

—

(3003396) Base excess in Arterial blood by calculation

3751

17166

1.81

218.38

8.0

7.5

mmol/l

1.0

0.9

1.14

2988

13404

(3027801) Oxygen [Partial pressure] in Arterial blood

3727

17145

1.80

212.96

8.0

7.5

kpa

12.3

13.4

22.72

3567

16409

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3727

17157

1.80

212.43

8.0

7.5

kpa

5.1

5.64

3568

16417

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2435

9752

2.04

211.02

1.6

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3804

17662

1.78

210.56

1.3

1.2

iu/ml

125.3

152.3

3.57

1257

7120

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2277

8905

2.09

210.29

1.1

u/ml

5.6

9.6

0.37

141

(3042936) Bacteria identified in Isolate by Culture

5121

25824

1.66

210.21

2.2

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2863

12272

1.91

204.08

1.7

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5184

26555

1.63

199.02

2.2

29.4

29.6

1.22

5011

25788

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4177

20222

1.71

198.92

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

483

791

4.87

198.53

1.9

1.4

iu/ml

1878510.1

1547490.8

0.22

(3019225) pH of Specimen

3510

16192

1.79

197.83

3.8

3.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2991

13153

1.87

196.82

1.1

1.0

—

(3000494) Fungus identified in Specimen by Culture

4643

23230

1.66

195.20

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7082

39357

1.52

190.08

1.3

iu/ml

26.9

33.0

1.72

1760

12796

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1401

4720

2.39

184.83

1.4

ug/g

299.7

287.3

0.82

722

2643

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1476

5101

2.34

183.93

2.2

2.4

ug/l

380.9

448.7

0.42

1339

4701

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2069

8216

2.05

182.71

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

10631

64411

1.43

182.51

2.4

2.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1432

4920

2.35

180.79

1.3

1.4

mg/l

478.2

530.1

0.65

1355

4709

(3016502) Oxygen saturation in Arterial blood

3276

15204

1.77

179.98

8.5

8.0

95.5

96.2

7.34

3171

14622

(3009214) Lutropin [Units/volume] in Serum or Plasma

2056

8259

2.02

175.75

1.4

u/l

9.0

9.6

1.22

1617

6887

(21494755) Public health laboratory ask at order entry panel

2744

36292

0.56

174.53

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1296

4330

2.41

174.00

1.4

1.5

e6/l

4094.1

1691.4

0.38

1020

3538

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1294

4325

2.41

173.58

1.3

1.4

e6/l

25.8

32.9

0.27

958

3360

(3020779) Urea [Moles/volume] in Serum or Plasma

3022

13848

1.79

172.99

7.3

8.4

mmol/l

7.5

8.7

22.48

2886

13318

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2387

10248

1.90

168.10

6.8

7.5

mmol/l

24.9

24.7

1.97

2361

10178

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1274

4309

2.38

166.41

1.2

1.3

mmol/l

3.7

3.6

1.45

1187

4049

(3007463) Buprenorphine [Presence] in Urine

117

48.70

165.25

7.5

6.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8757

52094

1.43

162.27

1.6

mmol/l

1.5

1.4

36.78

7663

44821

(3052851) Hemolysis interference index of Serum or Plasma

1419

5085

2.25

162.25

2.8

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1588

5992

2.14

159.89

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1597

6050

2.13

159.16

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1599

6072

2.13

158.38

1.2

—

(3007461) Platelets [#/volume] in Blood

34629

263175

2.42

156.70

24.9

15.1

e9/l

263.6

257.0

68.73

33978

257114

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4137

21171

1.61

156.27

6.9

5.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6581

37309

1.48

156.12

1.3

u/ml

8.2

10.6

2.11

2289

15869

(3027945) Reticulocytes/100 erythrocytes in Blood

3451

16871

1.68

156.06

2.6

2.7

1.8

1.7

0.95

3022

15209

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

193

145

10.54

155.09

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

134

20.79

150.76

1.5

1.1

mmol/l

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3011

14329

1.72

150.09

8.9

8.3

g/l

123.8

122.6

2.30

2921

13789

(3024731) MCV [Entitic volume]

34635

263523

2.39

150.05

24.8

15.1

90.2

0.28

34312

260567

(3029937) Albumin [Presence] in Urine by Test strip

9146

55458

1.40

149.82

4.5

3.5

estimate

0.0

2.87

3303

19604

(3035941) MCH [Entitic mass]

34632

263502

2.38

149.78

24.8

15.1

30.1

2.32

34312

260554

(3026361) Erythrocytes [#/volume] in Blood

34637

263566

2.39

149.55

24.9

15.1

e12/l

4.5

4.6

28.10

33926

256973

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8141

48381

1.42

149.48

2.4

2.1

—

(3010813) Leukocytes [#/volume] in Blood

34640

263652

2.38

148.30

25.0

15.2

e9/l

6.9

6.6

117.56

33922

257026

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

156

+∞

148.10

6.4

0.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

34639

263703

2.37

146.86

25.1

15.2

g/l

135.8

137.0

49.10

34326

260779

(3022313) Gas panel - Capillary blood

1731

6966

2.01

146.62

3.7

3.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3003

14375

1.71

146.36

1.2

—

(3003181) Sodium [Moles/volume] in Urine

764

2134

2.86

146.23

1.5

mmol/l

56.9

68.2

8.59

584

1725

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1711

6871

2.01

145.76

3.8

3.0

1.6

1.2

23.39

1703

6832

(3005719) IgG [Mass/volume] in Serum or Plasma

3198

15655

1.67

143.22

2.4

2.7

g/l

10.4

10.6

0.81

2897

14439

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3147

15352

1.68

142.78

2.3

au/ml

22.2

21.9

0.04

157

1192

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

987

3231

2.45

138.22

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

987

3233

2.45

138.04

1.4

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3738

19196

1.60

137.98

17.0

19.0

inr

1.2

1.81

561

3096

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1664

6747

1.99

137.84

3.8

3.0

0.6

0.7

1.98

1601

6485

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2919

14108

1.69

136.87

1.3

au/ml

42.4

46.2

0.25

626

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3175

15696

1.65

136.56

2.5

2.2

nmol/l

11.6

12.7

10.39

2760

14393

(3044290) Cell count panel - Cerebral spinal fluid

1166

4144

2.26

135.68

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

9836

95930

0.73

133.92

2.5

2.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1859

7935

1.89

132.36

9.5

10.2

mmol/l

24.4

24.3

0.62

1708

7517

(3003327) Ova and parasites identified in Stool by Light microscopy

1900

8169

1.88

132.31

1.8

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1552

6230

2.01

132.13

3.7

3.5

mmol/l

24.7

0.33

1480

5812

(40760892) CBC W Ordered Manual Differential panel - Blood

8520

51946

1.39

131.85

4.9

4.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1436

5613

2.06

131.46

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7041

41651

1.41

129.73

3.0

2.8

ng/l

932.8

1011.6

0.60

5592

34840

(3023323) Follitropin [Units/volume] in Serum or Plasma

3044

15102

1.64

128.74

1.4

1.3

iu/l

21.1

27.2

21.05

2456

13234

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2113

9481

1.80

128.31

9.6

9.7

1.6

1.3

17.50

2105

9423

(3004119) Hemoglobin [Mass/volume] in Venous blood

2046

9102

1.82

127.77

4.1

3.4

g/l

132.3

131.0

2.00

2002

8897

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2105

9466

1.80

126.86

9.7

9.8

0.7

1.66

2097

9415

(3024928) Oxygen saturation in Venous blood

945

3191

2.37

123.59

3.8

3.9

—

(3019060) Gas panel - Arterial blood

2067

9373

1.78

120.98

5.5

4.8

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

399

839

3.78

119.82

1.4

1.5

mu/l

622.6

470.2

1.34

375

808

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1155

4301

2.15

119.80

1.4

1.3

u/l

20.1

26.0

8.15

926

3631

(3008295) Osmolality of Serum or Plasma

538

1380

3.10

119.37

1.6

mosm/kgh2o

281.2

281.9

0.23

391

1125

(4010399)

2751

13552

1.65

119.20

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

403

861

3.72

118.36

1.4

72.9

72.6

0.20

379

830

(3014007) Fractional oxyhemoglobin in Arterial blood

2082

9540

1.77

117.52

9.9

9.8

93.4

94.4

7.92

2076

9509

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25318

182288

1.33

117.12

4.0

3.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1002

3568

2.25

115.93

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2545

12383

1.67

115.53

2.6

2.1

ug/l

6.1

7.8

2.44

2140

10948

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

977

3472

2.25

113.56

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

131

11.91

113.47

1.1

1.2

mg/l

55.0

40.1

1.93

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15075

101595

1.29

112.65

4.1

3.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1861

8364

1.80

112.01

1.6

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2474

12065

1.66

111.17

1.8

g/l

1.3

0.45

2252

11171

(3023410) Appearance of Cerebral spinal fluid

662

1994

2.65

109.89

1.5

1.6

—

(3025941) Bacteria identified in Stool by Culture

2691

13466

1.62

109.15

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1976

9149

1.74

107.32

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

997

3657

2.18

107.30

1.4

1.2

—

(40761535) Cells panel - Urine sediment

2772

14051

1.60

106.55

3.8

3.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2735

13880

1.60

104.52

3.4

3.7

mmol/l

1.2

2.10

2338

12224

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1009

3758

2.15

104.51

3.1

2.9

mmol/l

24.7

24.5

0.92

901

3287

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2481

12323

1.63

103.48

3.6

4.1

ng/l

79.1

86.5

3.81

2152

10906

(3028626) Oxygen [Partial pressure] in Capillary blood

992

3703

2.14

102.15

3.3

3.2

kpa

8.8

8.7

0.82

930

3443

(1616796) Gas panel - Central venous blood

949

3485

2.18

101.81

3.2

3.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1382

5859

1.89

99.96

1.3

titre

78.1

128.0

2.76

118

568

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2562

30358

0.64

97.81

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1889

8868

1.72

97.44

1.3

1.2

u/ml

0.8

1.0

0.31

144

749

(3004716) Salmonella sp identified in Stool by Organism specific culture

2685

13822

1.57

96.25

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

2414

12157

1.61

94.89

2.4

2.8

e9/l

72.7

70.2

2.37

1732

9080

(3018405) Lactate [Moles/volume] in Arterial blood

1192

4918

1.94

93.43

4.5

4.0

mmol/l

1.4

1.3

1.11

1182

4833

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12591

84294

1.27

93.12

4.2

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1070

4267

2.01

92.41

1.3

—

(3010421) pH of Blood

1060

4220

2.01

91.97

3.7

3.5

7.4

5.07

894

3565

(3005322) IgE [Units/volume] in Serum or Plasma

2969

15827

1.52

90.77

1.4

1.3

u/ml

276.9

234.2

0.50

2725

14773

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1931

9301

1.67

90.41

8.4

6.7

mmol/l

24.7

24.5

1.06

1830

8612

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

30238

226141

1.36

86.51

4.6

4.1

mmol/l

2.8

2.9

15.92

28182

213178

(3017509) Phencyclidine [Presence] in Urine

166

217

6.05

86.50

2.3

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

792

2900

2.18

85.55

1.9

1.8

titre

5099.5

3106.8

0.37

127

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1571

7259

1.74

85.54

1.9

1.7

nmol/l

39.0

39.7

0.48

1528

7148

(3009542) Hematocrit [Volume Fraction] of Blood

29953

223836

1.35

84.58

18.0

10.9

40.1

40.5

16.80

22884

180912

(3020891) Body temperature

1311

5778

1.82

83.75

6.0

4.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1312

5788

1.82

83.55

1.2

1.3

titre

910.4

988.7

0.12

173

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2003

9937

1.62

83.38

1.6

mg/l

3.6

3.4

0.48

1552

6500

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1423

6453

1.77

82.65

4.4

3.6

51.4

48.8

3.35

1406

6389

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1121

4721

1.90

82.58

1.5

1.4

nmol/l

0.4

0.34

915

3754

(3027315) Oxygen [Partial pressure] in Blood

926

3657

2.02

82.11

3.8

3.5

kpa

9.0

8.9

1.05

899

3587

(3012501) Base excess in Blood by calculation

921

3631

2.03

82.05

3.8

3.5

mmol/l

2.3

0.00

610

2361

(3013290) Carbon dioxide [Partial pressure] in Blood

921

3633

2.02

81.93

3.8

3.5

kpa

5.1

5.0

4.13

894

3564

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1451

6640

1.75

81.67

1.8

g/l

0.2

0.05

1379

6313

(3020961) Endomysium IgA Ab [Titer] in Serum

2346

12162

1.56

81.04

1.1

titre

198.3

195.8

0.01

371

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1482

6847

1.74

80.66

1.8

g/l

1.2

1.12

1407

6532

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1132

4820

1.88

80.63

2.1

1.8

pmol/l

185.3

199.4

3.71

1069

4649

(3043409) Potassium [Moles/volume] in Arterial blood

1035

4279

1.93

80.56

4.9

4.3

mmol/l

3.8

3.9

2.56

954

4033

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

529

1691

2.49

77.89

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2354

12320

1.54

77.82

2.1

2.6

g/l

66.8

66.9

0.59

2136

11408

(3022145) Colonoscopy Study observation

3989

23144

1.40

77.81

1.3

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

473

1433

2.62

77.70

1.4

1.3

umol/l

5.6

5.5

0.06

434

1335

(3027273) Bicarbonate [Moles/volume] in Venous blood

1496

7014

1.71

77.20

4.2

3.3

mmol/l

25.4

25.3

0.40

1457

6791

(3017181) Myelocytes/100 leukocytes in Blood

2973

16396

1.47

76.36

4.3

4.1

0.9

0.31

767

4164

(3021901) Oxygen saturation in Capillary blood

712

2667

2.13

72.64

2.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

656

2392

2.18

71.61

1.5

1.6

—

(3016038) Potassium [Moles/volume] in Urine

323

838

3.06

70.47

1.3

1.4

mmol/l

32.2

35.3

1.31

281

743

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

29818

223884

1.31

70.07

4.2

3.8

mmol/l

4.7

4.8

68.41

27957

212466

(3012516) Albumin [Mass/volume] in Urine

7617

49329

1.28

69.03

3.3

mg/l

421.8

434.6

0.08

4907

31070

(3029634) Reagin Ab [Titer] in Serum by VDRL

877

3619

1.93

68.61

2.2

2.1

titre

7.4

7.0

0.04

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7233

46583

1.28

68.45

1.6

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

2822

15725

1.45

68.33

4.4

4.1

0.1

0.33

692

3900

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

541

1857

2.32

68.19

1.8

2.3

nmol/l

21.4

20.5

0.95

507

1790

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3826

22511

1.38

68.02

4.0

3.8

30.4

32.2

19.44

2822

16265

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

598

2148

2.21

67.74

1.3

nmol/l

22.9

26.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2707

15006

1.46

67.32

3.9

0.5

0.6

1.02

531

3086

(3020682) Albumin/Creatinine [Ratio] in Urine

7911

51758

1.26

65.27

4.0

mg/mmol

10.1

8.7

1.36

5059

33062

(43055514) Macroprolactin [Presence] in Serum or Plasma

273

674

3.21

64.68

1.3

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

599

2198

2.17

64.40

1.4

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3292

19067

1.40

64.07

3.5

4.5

u/l

225.1

240.2

9.24

3083

18192

(3037121) Protein [Mass/volume] in Urine

1289

6121

1.68

63.32

3.0

3.4

g/l

0.3

0.22

559

2802

(3028271) Lactate [Moles/volume] in Capillary blood

650

2485

2.08

62.92

2.2

1.7

mmol/l

1.8

1.7

1.88

639

2427

(3008898) HLA-B27 [Presence]

1855

9664

1.54

62.24

1.1

—

(40768804) Tissue Pathology biopsy report

12883

89216

1.22

61.97

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

573

2107

2.16

61.30

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

29574

222602

1.28

61.27

4.2

3.7

mmol/l

1.4

1.5

190.68

27593

210719

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1125

5198

1.73

61.06

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1072

4897

1.75

60.56

1.3

u/ml

256.5

251.0

0.26

714

3153

(3025159) Blasts/100 leukocytes in Blood

2661

15004

1.43

60.14

4.4

4.2

0.0

0.2

2.24

568

3343

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3063

17707

1.40

60.08

3.8

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

802

3370

1.90

59.45

2.8

2.3

17.1

17.0

0.26

416

1692

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1798

20790

0.66

58.74

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

491

1727

2.26

58.54

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

747

3086

1.93

58.26

1.4

1.3

—

(3036489) Thrombin time

1587

8123

1.57

57.52

2.2

21.0

21.2

0.49

1365

6919

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1663

8620

1.55

56.99

10.8

9.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1587

8193

1.55

55.36

1.4

1.6

u/ml

8.0

12.7

0.94

277

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

456

1593

2.27

55.27

1.1

mg/l

294.0

290.1

0.47

409

1442

(3016244) Insulin [Units/volume] in Serum or Plasma

470

1671

2.23

54.65

3.1

3.3

mu/l

30.0

25.8

1.45

431

1584

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

529

1975

2.13

54.51

1.2

mg/l

33.8

43.1

4.52

442

1648

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1282

6333

1.62

53.93

1.3

u/ml

32.3

36.6

0.22

413

(3004588) Protein electrophoresis panel - Serum or Plasma

1836

9842

1.50

53.72

1.9

2.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1026

4840

1.69

51.61

1.3

1.2

u/ml

45.8

42.1

0.26

483

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

274

774

2.80

51.61

2.5

2.3

umol/l

50.6

53.1

0.68

229

662

(3034274) Bile acid [Moles/volume] in Serum --fasting

961

4455

1.72

51.53

2.1

2.2

umol/l

5.2

6.1

1.53

701

3273

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1437

7373

1.56

51.47

2.2

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4490

28133

1.30

50.86

1.9

1.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

508

1922

2.10

50.61

1.1

mg/l

220.8

253.9

2.52

447

1695

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

251

684

2.91

50.46

1.5

1.4

pmol/l

13.9

14.9

1.62

200

593

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1079

5194

1.66

50.28

1.3

1.5

iu/ml

17.7

12.7

0.33

131

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1298

6550

1.58

49.95

1.7

1.6

titre

256.4

320.2

0.31

263

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

653

2723

1.91

49.58

1.3

nmol/l

0.2

0.66

134

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

28489

214677

1.23

49.43

3.8

3.4

mmol/l

1.4

1.3

104.77

26405

202704

(4027681)

431

1544

2.22

49.26

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1666

8920

1.50

48.95

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1310

6657

1.57

48.92

2.1

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1176

5832

1.61

48.67

1.9

2.0

iu/l

11.7

19.9

0.30

408

2355

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

653

2748

1.89

48.23

1.3

nmol/l

1.2

1.4

0.11

628

2654

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1873

10295

1.46

48.21

1.4

1.3

miu/ml

211.8

227.2

1.01

764

5273

(1002224) Polysomnography panel

1978

11002

1.44

47.81

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

66.59

47.45

1.3

1.4

nmol/l

27.6

24.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1280

6530

1.57

46.98

2.7

173.9

176.9

0.58

1192

6210

(3017732) Neutrophils [#/volume] in Blood

2609

15287

1.37

46.66

3.2

2.2

e9/l

4.3

4.1

2.38

2010

12572

(3022806) Fractional oxyhemoglobin in Capillary blood

523

2065

2.01

46.50

2.2

1.6

90.6

90.8

0.39

517

2033

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

904

4240

1.70

46.46

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1349

6994

1.54

46.08

1.8

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1326

6852

1.55

45.98

1.8

1.9

g/l

1.5

1.4

0.24

1161

5883

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

592

2453

1.92

45.84

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

900

4239

1.69

45.55

1.8

2.2

g/l

0.0

0.67

826

3925

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

426

1570

2.15

45.44

1.2

1.3

mmol/l

1.9

2.0

1.08

392

1470

(3024980) IgG subclass 4 [Mass/volume] in Serum

783

3550

1.76

45.43

1.5

1.6

g/l

0.7

0.98

622

2695

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

905

4277

1.69

45.23

1.8

2.2

g/l

38.9

38.3

1.74

795

3739

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

331

1099

2.39

45.13

1.1

nmol/l

3.1

6.6

0.68

210

(3003338) MCHC [Mass/volume]

27781

209287

1.21

45.08

21.6

12.7

g/l

333.0

333.2

3.34

27610

207707

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1066

5280

1.61

44.33

1.8

2.3

g/l

2.9

3.0

2.18

857

4150

(3040151) Glucose [Moles/volume] in Capillary blood

465

1792

2.06

44.19

7.9

3.6

mmol/l

7.1

0.07

384

1460

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

831

3880

1.70

43.44

1.9

2.2

g/l

0.0

0.87

759

3577

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

478

1878

2.02

43.12

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1107

5573

1.58

43.01

1.8

2.2

g/l

7.1

7.3

1.66

870

4243

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

415

1549

2.13

42.89

1.2

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1712

9461

1.45

42.75

2.9

2.4

e6/l

0.3

0.17

1662

9140

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

966

4712

1.63

42.74

1.9

2.3

g/l

0.4

0.7

2.69

858

4146

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

413

1541

2.13

42.73

1.2

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1101

5546

1.58

42.67

2.3

2.0

ug/l

2.5

2.1

0.59

973

4947

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1104

5566

1.58

42.63

1.8

2.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2145

12349

1.39

42.57

2.8

2.6

ng/l

134.3

156.1

1.58

1890

11091

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1102

5561

1.58

42.39

1.8

2.2

g/l

3.7

3.8

1.51

841

3994

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1039

5178

1.60

42.13

1.8

2.2

g/l

9.9

10.2

1.40

891

4392

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1005

4971

1.61

42.04

1.4

1.5

u/ml

20.6

20.7

0.01

104

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

819

3845

1.70

41.97

1.9

2.2

g/l

0.0

0.00

758

3573

(3006922) Hepatitis E virus Ab [Presence] in Serum

410

1540

2.11

41.71

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1007

5000

1.60

41.46

1.4

1.5

—

(3036180) Methadone [Presence] in Urine

47.35

41.32

2.9

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9018

62192

1.19

40.71

3.5

2.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1139

5866

1.55

40.08

1.3

u/ml

8.6

10.2

0.28

148

943

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

200

552

2.87

39.43

2.6

2.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

286

950

2.38

39.04

1.8

1.9

umol/l

2.0

0.23

267

896

(3025130) Human papilloma virus identified in Specimen

828

4004

1.65

37.94

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

811

3904

1.65

37.82

2.2

2.1

g/l

134.1

132.9

0.64

595

2854

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1229

6515

1.50

37.82

2.9

2.7

g/l

3.6

0.21

1156

6215

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1626

9104

1.43

37.77

1.9

2.1

u/l

39.8

39.7

0.06

1482

8305

(3020717) Zinc [Moles/volume] in Serum or Plasma

311

1089

2.26

37.67

1.6

1.5

umol/l

20.1

27.6

5.10

298

1047

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

172

448

3.04

37.54

1.5

1.2

nmol/l

134.1

124.5

0.26

115

356

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1110

5788

1.53

36.92

1.3

u/ml

8.5

7.2

0.17

636

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

925

4630

1.59

36.85

1.3

u/ml

3.0

5.1

0.57

373

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

737

3487

1.68

36.73

1.1

iu/ml

1059.7

686.3

0.14

181

888

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

933

4686

1.58

36.63

1.4

1.5

u/ml

104.1

110.5

0.80

178

1051

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

359

1350

2.11

36.49

1.1

u/l

1.0

1.1

0.99

153

605

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

199

574

2.74

36.23

3.0

2.9

umol/l

28.6

28.2

0.13

139

451

(3051611) Lipemic interference index of Serum or Plasma

436

1768

1.96

36.07

3.5

3.1

—

(40761536) Microorganisms panel - Urine sediment

2971

18394

1.30

36.07

4.3

3.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

369

1409

2.08

36.04

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

249

807

2.44

35.90

1.9

2.0

umol/l

28.4

29.1

0.56

243

780

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1175

6240

1.50

35.85

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

902

4525

1.59

35.60

1.2

u/ml

17.8

18.3

0.01

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1315

7162

1.46

35.38

2.4

94.4

93.9

0.25

1213

6648

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

369

1421

2.06

35.25

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

549

2418

1.80

35.22

1.3

nmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1347

7377

1.46

35.22

1.1

u/ml

5.4

4.8

0.13

150

1209

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

427

1735

1.95

35.14

1.1

1.2

u/ml

90.6

65.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

277

953

2.30

35.00

1.4

1.2

u/l

266.6

325.2

0.49

254

892

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

191

552

2.74

34.68

1.9

2.0

—

(3051651) Icteric interference index of Serum or Plasma

292

1033

2.24

34.57

3.8

3.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

478

2030

1.87

34.46

2.1

1.9

mg/l

22.1

26.0

0.77

130

546

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

410

3.03

34.17

3.1

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

410

3.03

34.17

3.1

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

1068

2.20

33.82

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

239

783

2.42

33.70

1.2

111.2

110.3

0.20

214

700

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

161

434

2.93

33.19

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

192

570

2.66

33.14

1.1

1.3

95.1

91.5

0.90

186

563

(3026493) Urate [Moles/volume] in Serum or Plasma

7585

52286

1.18

33.12

2.4

umol/l

2164.5

3558.2

4.16

6517

46798

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

1030

2.20

32.47

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

532

2382

1.77

32.34

1.4

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

420

1747

1.91

32.30

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

532

2383

1.77

32.30

1.4

1.5

—

(3047181) Lactate [Moles/volume] in Blood

1006

5289

1.51

32.22

6.8

5.2

mmol/l

1.3

1.2

2.35

891

4682

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

189

565

2.65

32.20

1.1

1.3

—

(3045716) Anion gap in Serum or Plasma

201

620

2.56

32.18

2.4

2.5

mmol/l

8.7

9.0

0.63

150

438

(3005988) Vibrio sp identified in Specimen by Organism specific culture

532

2386

1.77

32.16

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

774

3837

1.60

32.14

2.8

2.3

nmol/l

0.9

0.8

3.81

638

3282

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

420

1750

1.90

32.14

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

536

2410

1.76

32.13

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

275

979

2.22

32.11

1.6

nmol/l

21.0

5.9

0.37

228

808

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

420

1751

1.90

32.08

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

178

518

2.72

31.94

1.4

1.3

umol/l

17.1

16.8

0.25

157

463

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

440

1866

1.87

31.91

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

423

1772

1.89

31.85

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

423

1773

1.89

31.80

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

423

1776

1.89

31.64

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1235

6796

1.45

31.49

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

535

2419

1.75

31.46

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

543

2466

1.75

31.45

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

818

4140

1.57

31.13

1.6

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

266

4314

0.48

31.05

1.5

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

331

1285

2.04

31.01

1.4

1.5

ug/l

6.3

7.6

1.25

299

1164

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

16.91

30.94

1.3

1.0

mmol/l

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

383

1569

1.93

30.85

1.4

umol/l

10.9

11.4

0.82

351

1521

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

243

837

2.30

30.69

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

246

853

2.28

30.60

1.2

g/l

0.3

0.43

199

675

(3023420) DNA double strand Ab [Units/volume] in Serum

549

2526

1.72

30.39

1.5

1.6

iu/ml

25.3

33.8

0.91

128

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

526

2395

1.74

30.21

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

601

2841

1.68

30.13

1.3

u/ml

54.7

52.3

0.05

203

(3012920) Ethanol [Mass/volume] in Serum or Plasma

35.94

29.95

1.7

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

303

1154

2.08

29.90

1.4

1.5

u/l

5.9

5.6

0.16

251

990

(3019977) pH of Arterial blood

224

756

2.34

29.66

2.7

2.2

7.4

0.30

265

(3011985) Renin [Units/volume] in Plasma

568

2668

1.69

29.18

1.7

mu/l

68.1

61.7

0.27

495

2423

(40757494) Bilirubin.total [Moles/volume] in Blood

224

764

2.32

28.97

2.1

umol/l

16.0

27.5

0.88

(3027135) IgG subclass 1 [Mass/volume] in Serum

497

2256

1.75

28.88

1.4

g/l

6.5

6.8

0.92

377

1563

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1755

10413

1.35

28.64

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1754

10408

1.35

28.61

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

495

2253

1.74

28.50

1.4

g/l

2.9

3.0

0.30

374

1560

(3024139) IgG subclass 3 [Mass/volume] in Serum

495

2254

1.74

28.46

1.4

g/l

0.4

0.15

374

1564

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1744

10360

1.34

28.24

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1151

6383

1.44

28.17

6.1

4.7

2.1

1.6

13.45

1083

5987

(4062490)

495

2262

1.74

28.11

1.5

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

384

1628

1.87

27.94

1.3

nmol/l

1.5

1.4

1.31

355

1461

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1746

10391

1.34

27.92

1.4

—

(3011648) Oxygen content in Venous blood

334

1352

1.96

27.91

3.1

3.0

11.5

11.3

0.31

334

1352

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

743

3773

1.56

27.91

1.3

u/ml

3.8

0.01

319

1731

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

782

4018

1.55

27.88

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

591

2841

1.65

27.83

1.1

g/l

1.5

0.39

530

2601

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

235

833

2.23

27.81

1.0

ng/l

246.4

360.1

1.90

177

613

(3044242) Glucose [Moles/volume] in Arterial blood

189

610

2.45

27.63

2.0

1.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

236

841

2.22

27.58

1.0

ng/l

35.7

41.1

1.26

175

608

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

235

839

2.22

27.34

1.0

ng/l

856.0

735.6

3.27

174

596

(44813793)

404

1757

1.82

27.14

1.1

—

(3003694) ABO and Rh group [Type] in Blood

9913

70632

1.15

27.00

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1844

11122

1.32

26.89

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

1570

9259

1.35

26.66

1.9

1.7

—

(40768443) Skin Pathology biopsy report

1481

8659

1.36

26.58

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

943

5091

1.47

26.58

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1310

7515

1.39

26.44

1.5

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1114

6219

1.43

26.30

1.1

u/ml

1.7

1.9

0.32

498

2496

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

451

2047

1.75

26.27

6.9

6.4

mg/l

10.9

0.03

408

1915

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

185

610

2.40

25.87

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1119

6278

1.42

25.70

6.2

4.8

0.9

1.02

1057

5895

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

262

1005

2.06

25.46

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

336

1407

1.89

25.45

1.4

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

194

659

2.33

25.40

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

580

2842

1.62

25.36

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

328

1368

1.90

25.16

2.0

2.2

101.8

97.8

1.19

302

1258

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

750

3917

1.52

24.86

1.3

1.2

u/ml

4.4

3.5

0.73

256

1363

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

217

782

2.19

24.74

2.1

2.5

ug/l

1.1

0.10

207

732

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

583

2879

1.61

24.71

1.7

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

188

642

2.32

24.35

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1456

8623

1.35

24.04

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

929

5100

1.45

24.04

1.3

ug/l

3.4

3.7

0.77

851

4641

(3003888) Timothy IgE Ab [Units/volume] in Serum

1005

5603

1.43

23.93

1.1

u/ml

6.1

6.3

0.13

583

2929

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

280

1129

1.96

23.75

1.1

u/ml

7.8

11.7

1.02

219

(3041806) Other cells [#/volume] in Blood by Manual count

340

1463

1.84

23.71

1.5

1.4

—

(3001556) Androgen free Index in Serum or Plasma

116

316

2.90

23.64

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1422

8423

1.34

23.46

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

415

1904

1.73

23.34

1.5

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2888

27470

0.81

23.28

2.5

2.6

ug/l

0.6

0.7

17.27

1841

14980

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1423

8440

1.34

23.27

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

373

1661

1.78

23.26

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

508

2465

1.63

23.15

1.4

pmol/l

385.5

309.4

2.34

396

1929

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

171

578

2.34

22.71

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

958

5353

1.42

22.54

1.1

u/ml

2.4

2.3

0.09

258

1338

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1031

5846

1.40

22.32

1.9

2.2

mg/l

10.8

10.4

0.76

963

5487

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1602

9747

1.31

21.93

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

177

619

2.26

21.76

1.2

1.3

12.8

19.1

0.47

116

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

599

3075

1.54

21.55

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

164

558

2.32

21.49

1.1

mg/g

5.7

7.2

1.83

158

526

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

106

290

2.89

21.48

1.2

1.3

ng/l

45.4

77.1

1.07

197

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

259

1054

1.94

21.45

1.2

1.3

73.2

66.3

0.55

130

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

586

2997

1.55

21.44

1.6

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

387

1786

1.72

21.36

1.2

titre

189.5

213.7

0.21

301

(3011897) Casein IgE Ab [Units/volume] in Serum

136

426

2.52

21.30

1.1

1.2

u/ml

1.6

8.3

0.91

103

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

349

1568

1.76

21.17

2.6

e6/l

898.0

698.9

3.71

128

634

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

467

2272

1.63

21.11

1.6

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

385

1782

1.71

21.03

1.2

titre

85.5

171.6

1.10

(3014271) Vancomycin [Susceptibility]

154

515

2.36

20.99

3.2

2.6

—

(3022621) pH of Urine by Test strip

2092

13245

1.26

20.92

3.1

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

942

5320

1.41

20.90

1.1

u/ml

1.3

1.2

0.10

446

2269

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

710

3813

1.48

20.64

1.1

—

(4306422)

713

3834

1.48

20.60

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

327

1462

1.77

20.20

2.9

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4066

37031

0.85

20.15

3.5

21.6

21.8

0.37

1407

14805

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

883

4963

1.41

20.15

2.7

2.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

254

1063

1.89

19.42

1.2

1.3

u/l

20.4

21.3

0.10

216

915

(3030313) Adrenal Ab [Titer] in Serum

243

2.96

19.29

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

260

1100

1.87

19.23

1.2

1.3

u/l

92.4

82.4

0.56

224

960

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

112

336

2.63

19.18

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

407

1964

1.64

19.06

1.2

u/l

64.5

66.8

0.16

285

1334

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

680

3681

1.47

19.03

1.1

121.0

118.2

1.42

611

3349

(3004809) Band form neutrophils/100 leukocytes in Blood

529

2726

1.54

18.78

2.4

3.2

1.2

1.5

2.07

401

2141

(3049717) Cytology report of Urine Cyto stain

889

5075

1.39

18.56

2.1

2.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

275

1200

1.81

18.47

2.4

1.9

138.1

132.3

0.59

258

1136

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

785

4391

1.42

18.44

5.5

6.1

iu/ml

1231.4

1263.5

0.02

658

(3019897) Erythrocyte distribution width [Ratio] by Automated count

378

4771

0.62

18.42

3.6

2.2

13.2

13.1

1.08

373

4717

(3014051) Protein [Presence] in Urine by Test strip

786

4399

1.42

18.41

2.1

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

424

2086

1.61

18.39

1.5

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

172

3.30

18.34

2.1

2.0

umol/l

1.3

0.17

156

(3000492) Spirometry study

3544

23969

1.18

18.28

1.5

1.4

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

136

460

2.34

18.15

1.3

1.5

nmol/l

6.2

5.8

0.48

128

439

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

620

2.13

17.85

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

317

1464

1.71

17.56

2.5

2.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

125

414

2.38

17.50

1.5

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

612

3311

1.47

17.23

1.5

1.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

143

506

2.23

17.22

1.2

1.1

u/ml

3.8

7.7

0.66

101

344

(3008757) Leukocyte morphology finding [Identifier] in Blood

371

1805

1.63

16.89

3.0

3.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

310

1440

1.70

16.84

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

310

1440

1.70

16.84

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

310

1440

1.70

16.84

1.6

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

283

1285

1.74

16.68

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

117

3.71

16.64

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

136

479

2.24

16.58

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

607

3311

1.45

16.40

3.1

3.0

u/ml

418.7

6445.7

1.10

173

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

355

1722

1.63

16.37

1.6

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

187

749

1.97

16.36

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

652

3608

1.43

16.31

1.3

1.2

titre

64.4

170.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

187

750

1.97

16.30

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

102

319

2.52

16.16

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

339

1631

1.64

16.15

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

195

3.00

16.13

1.1

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

297

1385

1.70

15.94

4.0

4.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

136

488

2.20

15.88

1.1

—

(4268621)

500

2644

1.50

15.82

2.4

2.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

337

2.46

15.78

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

504

2674

1.49

15.69

1.1

96.0

95.6

0.13

466

2527

(21494815) CD4 cells/100 lymphocytes in Specimen

386

1933

1.58

15.64

2.4

2.2

44.8

42.4

0.52

250

(3012494) Peanut IgE Ab [Units/volume] in Serum

196

812

1.91

15.57

1.1

u/ml

1.8

8.7

1.37

127

452

(3032057) Clostridioides difficile [Presence] in Stool

100

316

2.50

15.53

2.0

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

839

4892

1.36

15.45

3.6

3.5

u/ml

0.3

0.70

485

2739

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

199

831

1.89

15.44

1.1

95.7

92.7

0.79

395

(3050129) First trimester maternal screen panel - Serum or Plasma

2056

13428

1.22

15.42

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

476

2510

1.50

15.28

1.5

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

123

431

2.25

15.22

1.3

1.6

nmol/l

0.3

0.2

0.08

312

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3001

20319

1.18

15.18

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2390

15874

1.20

15.05

2.7

2.4

ml/min/173m2

77.4

71.3

8.93

944

5849

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

134

490

2.16

14.97

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

731

4195

1.38

14.88

1.1

au/ml

12.6

11.5

0.13

339

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

135

3.33

14.79

2.2

2.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

106

353

2.37

14.75

1.1

1.0

ug/l

82.8

80.4

0.23

299

(3011412) CD3 cells [#/volume] in Blood

413

2137

1.53

14.52

2.5

2.4

e9/l

1.4

1.2

3.46

244

1290

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

194

821

1.87

14.49

1.1

95.7

94.2

0.18

399

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

487

2.14

14.44

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

188

790

1.88

14.35

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

202

871

1.83

14.24

2.4

1.9

149.8

152.7

0.14

193

823

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

270

1268

1.68

14.18

2.5

3.3

nmol/l

95.9

121.2

0.86

261

1251

(3027231) Wheat IgE Ab [Units/volume] in Serum

145

559

2.05

14.17

1.1

1.0

u/ml

1.4

2.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

199

856

1.84

14.14

1.1

1.2

111.9

108.7

0.47

180

765

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

174

717

1.92

14.10

2.9

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

321

1579

1.61

14.07

2.5

2.6

e6/l

561.7

511.2

1.19

272

1321

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

674

3855

1.39

14.03

1.1

—

(44790049)

400

2085

1.52

13.63

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

370

1897

1.54

13.60

1.7

1.6

—

(44790047)

400

2086

1.52

13.60

1.6

—

(44806118)

400

2086

1.52

13.60

1.6

—

(44790048)

400

2087

1.52

13.57

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

212

943

1.78

13.52

1.2

1.1

iu/ml

3.7

0.01

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

173

722

1.89

13.52

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

225

2.67

13.50

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

133

507

2.07

13.42

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

222

2.67

13.34

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

123

457

2.13

13.27

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

220

996

1.75

13.23

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

192

2.80

13.21

1.1

—

(3017569) Oxygen content in Arterial blood

147

585

1.98

13.21

1.9

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

303

1496

1.60

13.12

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

184

2.83

13.12

2.1

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

329

1657

1.57

13.10

2.7

3.2

58.5

57.4

0.37

207

1098

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

216

979

1.74

12.95

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

569

3208

1.40

12.94

2.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

310

1546

1.59

12.89

2.6

e9/l

0.2

0.07

268

1327

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

208

942

1.74

12.52

1.0

u/ml

7.9

12.5

1.08

115

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

4.73

12.38

1.1

1.0

pmol/l

288.0

307.9

0.14

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

671

3920

1.36

12.31

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

529

2972

1.41

12.30

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

726

4293

1.34

12.30

2.6

3.4

mg/l

51.2

60.8

0.29

601

3472

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

429

2322

1.46

12.21

1.6

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

112

415

2.13

12.21

1.3

1.2

pmol/l

379.2

311.6

0.73

320

(3033923) Metanephrine [Moles/time] in 24 hour Urine

105

380

2.18

12.14

1.1

umol/24h

0.7

4.5

0.51

193

(3000093) Morphology [Interpretation] in Blood Narrative

319

1625

1.55

12.13

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

276

2.40

12.12

1.0

u/ml

0.9

1.9

0.47

200

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

338

1745

1.53

12.11

1.2

1.3

u/ml

0.5

1.3

2.87

147

717

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

922

5654

1.29

12.04

4.8

3.9

mg/l

1.4

0.33

857

5296

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

385

2048

1.49

11.97

2.5

3.4

nmol/l

5.7

7.6

0.28

363

1984

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

414

2236

1.46

11.93

3.7

4.9

u/ml

62.0

114.2

1.27

114

730

(3044927) Protein electrophoresis panel - Urine

258

1255

1.63

11.93

1.2

—

(4024509)

326

1677

1.54

11.88

1.7

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

479

2663

1.42

11.84

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

578

3321

1.38

11.79

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

153

644

1.88

11.73

2.6

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

723

4307

1.33

11.67

1.6

1.7

e6/l

13945.0

11852.7

0.50

507

3162

(3002256) Pathology report gross observation

3872

27217

1.14

11.66

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

720

4288

1.33

11.65

2.6

3.4

mg/l

29.9

42.6

2.75

594

3471

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

702

4167

1.33

11.62

2.6

3.4

ratio

1.5

2.0

0.92

334

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1179

11456

0.80

11.52

2.1

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

314

1615

1.54

11.47

1.2

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

131

530

1.95

11.31

1.3

1.2

108.1

106.5

0.23

124

502

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

291

2.31

11.24

1.5

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

163

711

1.81

11.19

1.9

2.2

e6/l

214.2

209.2

0.05

105

386

(4146454)

298

1524

1.55

11.18

2.5

2.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

148

627

1.86

11.15

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

529

3026

1.38

11.12

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

308

1592

1.53

11.02

2.0

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

236

1148

1.62

10.96

1.9

—

(3039000) Anion gap in Blood

614

3607

1.35

10.92

8.9

6.4

mmol/l

11.2

11.1

0.23

562

3255

(3018572) Chloride [Moles/volume] in Blood

614

3608

1.35

10.90

8.9

6.4

mmol/l

105.0

105.4

1.17

562

3256

(3023419) Bacteria identified in Sputum by Culture

358

1917

1.48

10.83

2.5

2.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

246

1213

1.60

10.82

1.6

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

766

4653

1.30

10.80

1.1

u/ml

3.6

4.4

0.63

320

1828

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

220

2.48

10.67

1.6

mg/l

1.5

1.9

0.27

144

(3028717) Thiamine [Mass/volume] in Blood

202

2.54

10.60

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

346

2.14

10.49

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

327

1732

1.49

10.46

2.0

2.1

75.7

73.2

2.80

320

1678

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

233

1146

1.61

10.38

1.6

u/l

3.5

6.4

2.85

108

569

(3003721) Smooth muscle Ab [Units/volume] in Serum

159

2.73

10.32

1.1

u/ml

1.6

3.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

371

2022

1.45

10.28

1.4

nmol/l

29.7

32.6

1.14

334

1875

(3011841) English Walnut IgE Ab [Units/volume] in Serum

273

2.28

10.27

1.0

u/ml

1.9

1.3

0.17

199

(40761539) Cells [Type] in Urine sediment by Light microscopy

108

423

2.02

10.26

1.1

1.3

—

(3000330) Specific gravity of Urine by Test strip

1362

8912

1.21

10.10

3.4

3.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

3.4

4.3

0.56

133

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

1.8

2.0

0.14

158

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

2.1

2.5

0.17

157

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

2.3

2.0

0.16

145

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

1.1

1.3

0.21

134

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

1.7

0.00

156

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

1.1

0.9

0.25

148

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

3.3

2.1

0.75

151

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

217

2.44

10.05

1.6

mg/l

2.4

1.7

0.39

134

(3044941) Cell count panel - Synovial fluid

485

2784

1.38

10.04

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

470

2684

1.39

10.03

2.6

3.0

u/ml

78.9

294.4

0.86

436

2502

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

201

963

1.65

9.96

1.6

1.4

u/l

11.2

12.3

1.67

195

940

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

321

1714

1.48

9.90

2.0

2.1

11.4

13.8

3.69

177

859

(3023430) Cat dander IgE Ab [Units/volume] in Serum

713

4348

1.30

9.81

1.1

u/ml

5.8

5.0

0.45

320

1813

(3038177) Helicobacter pylori Ab [Presence] in Serum

713

4350

1.30

9.78

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

654

3944

1.31

9.77

1.3

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

160

2.66

9.70

1.0

u/ml

0.3

0.7

0.74

146

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

122

509

1.89

9.70

1.1

1.2

92.2

87.6

0.27

145

(3028433) Virus identified in Specimen by Culture

148

658

1.78

9.62

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

124

522

1.88

9.60

5.6

6.7

mmol/l

25.3

25.0

0.32

117

479

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1170

7583

1.22

9.57

1.7

1.6

iu/ml

7.0

4.4

0.22

239

1501

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.22

9.50

1.7

1.9

umol/l

49.2

45.7

0.26

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

127

2.86

9.42

1.3

1.4

pmol/l

7.2

14.1

0.83

105

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

174

817

1.68

9.34

1.1

ng/l

139.2

361.3

0.85

194

(3005011) Chlamydia sp Ab [Titer] in Serum

332

2.09

9.28

1.6

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

102

407

1.98

9.26

1.1

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

212

1050

1.60

9.24

2.2

2.3

ug/l

21.5

166.1

1.49

200

1004

(37021550) Renin [Units/volume] in Plasma --upright

381

2.01

9.20

1.4

mu/l

133.6

69.8

0.41

298

(3013945) Hepatitis B virus e Ab [Presence] in Serum

129

2.81

9.17

1.5

—

(3011048) Pyruvate [Moles/volume] in Blood

112

2.96

9.14

1.5

umol/l

92.3

70.9

1.91

102

(3027923) C peptide [Moles/volume] in Serum or Plasma

207

1022

1.60

9.14

1.6

1.7

nmol/l

1.3

1.2

0.49

148

835

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

179

855

1.65

9.03

1.4

1.3

titre

54.4

78.9

0.51

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

171

2.54

9.02

1.0

u/ml

0.4

2.5

1.45

133

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

177

2.50

8.89

3.9

4.5

mg/l

2.1

2.5

0.83

152

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5427

46324

0.91

8.87

3.8

4.0

ug/l

2.6

2.4

0.15

4813

42580

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

182

2.47

8.86

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

403

1.96

8.85

1.0

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

193

945

1.61

8.84

1.9

2.4

10.5

0.01

186

890

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

254

1327

1.51

8.77

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

182

881

1.63

8.73

1.4

1.3

titre

87.0

391.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

158

738

1.69

8.69

1.3

1.2

g/l

0.7

0.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

233

2.27

8.65

1.9

3.0

mmol/l

0.9

1.5

1.28

171

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

305

2.10

8.62

1.0

u/ml

1.1

3.8

0.65

156

(40768800) Prostate Pathology biopsy report

196

2399

0.64

8.61

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

300

2.10

8.61

1.0

u/ml

0.6

0.5

0.06

157

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

376

1.97

8.51

1.1

u/ml

0.1

0.3

1.06

234

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

105

1494

0.55

8.47

1.2

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

544

3267

1.32

8.45

3.3

2.6

mmol/l

1.5

0.03

537

3195

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

304

1661

1.45

8.42

1.1

iu/ml

7.9

7.7

0.05

492

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

241

2.23

8.42

1.2

—

(4034850)

1007

6517

1.22

8.41

11.3

7.2

—

(3024869) Neuronal Ab [Presence] in Serum

284

2.11

8.27

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

118

515

1.81

8.23

1.1

75.0

76.0

0.06

141

(3036603) Volume of Urine

246

1301

1.49

8.06

1.5

1.7

1628.1

1937.0

1.12

277

(3022493) Free Hemoglobin [Mass/volume] in Plasma

164

794

1.63

7.91

3.3

6.6

mg/l

67.2

4278.1

4.45

119

575

(3006442) Creatine [Moles/volume] in Serum or Plasma

282

1540

1.45

7.87

1.8

1.3

umol/l

63.2

71.3

1.17

144

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

597

3669

1.29

7.84

2.9

3.1

—

(3006270) Folate [Moles/volume] in Blood

278

1517

1.45

7.79

1.2

1.1

nmol/l

376.0

393.4

0.78

252

1362

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.25

7.71

1.1

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.60

7.70

1.0

u/ml

0.4

0.7

0.38

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

314

2.01

7.68

1.0

u/ml

0.1

0.2

1.61

185

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

182

911

1.58

7.68

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

182

911

1.58

7.68

1.8

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

182

911

1.58

7.68

1.8

2.1

—

(3010503) CD19 cells [#/volume] in Blood

236

1251

1.49

7.67

2.9

2.6

e9/l

0.2

0.3

1.21

228

1231

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

149

710

1.66

7.67

1.9

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

197

1006

1.55

7.62

1.5

1.4

u/ml

23.5

21.9

0.14

181

(3038026) Centromere Ab [Units/volume] in Serum

302

1682

1.42

7.59

1.3

1.2

u/ml

64.3

50.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

182

914

1.57

7.58

1.8

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

533

3250

1.30

7.46

2.5

3.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

373

2162

1.36

7.41

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

145

694

1.65

7.36

1.9

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

145

694

1.65

7.36

1.9

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

428

2537

1.33

7.35

1.4

mmol/l

12.1

11.5

0.63

143

451

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

253

1373

1.46

7.33

1.2

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

114

2.70

7.28

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

293

1637

1.41

7.26

1.1

ratio

1.1

0.04

599

(3027974) Hepatitis B virus e Ag [Presence] in Serum

133

2.55

7.20

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

115

2.68

7.17

1.1

1.7

10.2

13.3

0.41

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

601

3751

1.27

7.03

1.0

u/ml

0.4

0.5

0.36

143

745

(3014148) Varicella zoster virus Ab [Titer] in Serum

617

3869

1.26

6.95

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

160

2.37

6.90

1.2

nmol/l

17.0

14.5

0.33

(3051593) INR in Capillary blood by Coagulation assay

118

546

1.71

6.83

4.3

10.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.16

6.82

1.5

3.3

mu/l

2.1

2.4

0.11

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

282

1584

1.41

6.81

1.3

1.2

u/ml

15.3

9.5

0.26

116

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

201

2.20

6.81

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

196

2.21

6.80

1.1

1.0

u/ml

0.5

0.7

0.23

110

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

291

1644

1.40

6.80

1.3

1.2

u/ml

78.0

59.3

0.46

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.94

6.72

1.0

u/ml

0.0

0.36

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

234

1274

1.45

6.71

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

665

4225

1.25

6.70

1.1

u/ml

2.7

2.8

0.12

261

2348

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

260

2.03

6.69

2.9

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

181

936

1.53

6.68

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

239

2.08

6.68

1.1

1.4

52.2

56.1

0.23

127

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

291

1650

1.39

6.67

1.3

1.2

u/ml

73.7

43.6

0.79

125

(3033942) Copper [Moles/time] in 24 hour Urine

106

2.68

6.66

1.2

umol/24h

1.2

0.9

0.14

(3052592) Norovirus Ag [Presence] in Stool

289

1.97

6.56

1.1

1.3

—

(3037756) Immunofixation for Serum or Plasma

471

2879

1.29

6.54

1.5

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1841

12815

1.14

6.47

2.7

3.1

u/ml

52.4

43.5

0.23

1774

12407

(3045424) Erythrocytes [Presence] in Urine

575

3609

1.26

6.46

1.6

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

280

1.97

6.45

1.0

u/ml

0.1

0.6

1.49

151

(3020491) Glucose [Moles/volume] in Blood

283

1611

1.39

6.36

1.7

1.6

mmol/l

6.8

6.3

1.89

215

1214

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

136

668

1.61

6.30

2.2

ug/l

67.8

61.1

0.28

136

654

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

372

1.82

6.29

2.3

2.7

mg/l

35.0

48.5

0.39

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

134

658

1.61

6.22

3.4

3.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.74

6.21

1.0

u/ml

0.2

0.0

0.58

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

424

2576

1.30

6.19

1.2

1.3

u/l

27.9

33.1

0.33

377

2273

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

106

2.60

6.16

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

2.50

6.16

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.94

6.15

1.5

1.7

u/l

0.0

0.1

—

(3021788) Differential panel - Synovial fluid

540

3392

1.26

6.06

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.30

6.05

2.6

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

298

1726

1.36

6.05

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

299

1.90

5.99

1.5

1.6

nmol/l

136005.4

322612.1

0.53

261

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

222

1225

1.43

5.99

1.2

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

203

2.10

5.91

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

440

1.72

5.82

1.1

—

(3042631) Mycobacterium sp identified in Specimen

336

1995

1.33

5.81

2.8

2.6

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.97

5.81

1.1

u/l

605.3

303.3

0.54

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

162

1890

0.67

5.80

1.2

1.3

g/l

1.4

1.5

0.16

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

130

2.37

5.67

1.1

1.6

36.1

33.1

0.15

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.07

5.61

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

729

4772

1.21

5.58

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

251

1.95

5.58

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

3.31

5.58

1.0

—

0.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

215

1202

1.41

5.44

2.6

2.8

40.7

39.7

0.22

431

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

320

1907

1.33

5.43

1.7

2.2

32.2

32.7

0.98

314

1891

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

612

3951

1.22

5.40

2.4

2.5

ug/min

142.1

100.0

0.89

362

2511

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.57

5.37

1.0

1.5

0.3

1.4

1.92

(40768441) Liver Pathology biopsy report

266

1550

1.36

5.26

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.29

5.26

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

143

746

1.51

5.18

2.6

3.5

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.77

5.18

1.0

1.1

g/l

0.2

1.80

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

225

1283

1.38

5.11

1.2

u/ml

9.7

12.6

0.17

137

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

210

1.99

5.10

1.1

1.5

—

34.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1985

17341

0.90

5.10

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

761

5050

1.19

5.07

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

211

1.98

5.04

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

123

2.31

5.00

1.3

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.07

4.98

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

194

1085

1.41

4.94

8.8

5.9

u/ml

943.7

4356.4

0.58

217

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

174

959

1.43

4.82

1.2

u/l

98.8

78.6

1.13

137

787

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

453

1.64

4.81

1.1

—

(4015189)

388

1.69

4.77

2.4

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

482

3084

1.24

4.70

3.5

2.7

mmol/l

7.0

7.4

3.12

477

3025

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

593

1.54

4.66

1.6

ug/l

9.5

8.6

1.39

116

593

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

212

1.93

4.66

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

196

1.97

4.63

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

181

1013

1.41

4.63

1.6

u/field

1.9

2.6

0.87

130

740

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.41

4.61

1.6

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.70

4.60

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

202

1.95

4.60

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

552

1.56

4.57

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

172

958

1.42

4.53

1.2

u/l

33.9

20.1

0.80

131

762

(3049242) von Willebrand panel - Platelet poor plasma

2.80

4.49

1.4

1.8

—

(3013762) Body weight Measured

2.45

4.46

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

313

1.74

4.44

1.3

2.0

pmol/l

39.5

43.3

0.15

276

(3034426) Prothrombin time (PT)

158

870

1.43

4.44

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

944

1.41

4.39

1.7

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

392

1.65

4.37

2.5

2.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

315

1937

1.28

4.35

1.1

u/ml

0.7

3.2

1.36

111

499

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.81

4.32

1.0

pmol/l

171.1

209.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

173

974

1.40

4.31

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

3.32

4.30

1.3

1.1

mmol/l

3.4

0.02

(3000034) Microalbumin [Mass/volume] in Urine

257

1541

1.32

4.29

3.1

2.8

mg/l

70.2

54.2

0.37

174

1091

(40757373) Influenza virus identified in Isolate

323

1.71

4.26

1.9

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

307

1890

1.28

4.21

1.1

—

(3016750) Collection duration of Urine

174

985

1.39

4.21

2.1

2.3

min

529.4

495.5

4.65

135

787

(1761482) Bacteria [#/volume] in Urine by Culture

613

4066

1.19

4.19

4.5

3.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

118

2.21

4.18

1.1

u/l

7.4

11.0

0.67

118

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

193

1.92

4.16

1.1

umol/24h

1.5

3.6

0.56

193

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

296

1.73

4.15

1.9

2.3

mmol/l

6.7

7.8

1.21

173

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

152

843

1.42

4.14

1.7

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

850

1.42

4.13

1.7

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

3.94

4.07

1.3

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

101

518

1.54

4.06

1.7

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

125

2.15

4.04

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

284

1745

1.29

3.98

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.67

3.97

1.0

1.1

nmol/l

186.5

251.8

1.38

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

303

1879

1.27

3.95

1.7

—

(3024263) Appearance of Synovial fluid

163

924

1.39

3.94

1.7

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.34

3.93

3.9

3.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

523

3444

1.20

3.90

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

181

1046

1.37

3.90

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

286

1766

1.28

3.87

2.5

2.1

mmol/l

105.7

0.04

286

1746

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.77

3.85

5.9

4.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

138

763

1.43

3.85

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

149

2.01

3.85

1.1

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

286

1768

1.28

3.84

2.5

2.0

mmol/l

4.0

1.61

286

1748

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.20

3.83

1.1

1.4

e6/l

108.9

64.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

153

863

1.40

3.82

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

215

1280

1.33

3.82

1.1

miu/ml

1600.7

1412.2

1.69

215

1280

(3026250) Tacrolimus [Mass/volume] in Blood

184

1071

1.36

3.80

40.5

36.5

ug/l

7.4

0.10

170

983

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

187

1093

1.35

3.76

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.33

3.76

3.5

3.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.29

3.76

1.1

u/l

41.0

51.5

0.60

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

241

1.77

3.73

2.7

6.5

66.5

72.7

0.96

187

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

138

768

1.42

3.73

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

138

768

1.42

3.73

1.3

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

741

5048

1.16

3.71

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

158

903

1.38

3.67

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

200

1187

1.33

3.65

1.1

97.0

96.6

0.07

157

958

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

869

5997

1.15

3.65

3.1

3.7

u/ml

7785.4

1618.1

0.41

727

5166

(3023199) Leukocytes [#/volume] in Pleural fluid

232

1408

1.30

3.62

1.5

e6/l

4423.6

2814.2

0.46

173

996

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.44

3.53

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

205

1.81

3.52

1.0

u/ml

0.2

1.1

1.02

129

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.15

3.51

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

145

825

1.39

3.48

2.1

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

364

1.58

3.38

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

130

2.00

3.34

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

215

1.76

3.32

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

344

2214

1.23

3.31

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

136

1.97

3.31

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

305

1.63

3.30

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

190

1139

1.32

3.28

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

102

551

1.46

3.28

1.1

1.2

—

302.9

—

(37019676) Renin [Units/volume] in Plasma --supine

2.98

3.23

1.0

1.1

mu/l

27.4

47.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

847

5891

1.14

3.21

1.5

1.4

pmol/l

84.1

116.6

2.68

829

5748

(3007919) Fasciola sp Ab [Titer] in Serum

3.11

3.20

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

433

1.51

3.18

5.7

5.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

1.78

3.17

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

184

1106

1.31

3.14

2.8

2.7

au/ml

137.0

144.3

0.08

148

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

249

1.68

3.12

1.2

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

196

1.77

3.12

1.0

1.1

u/ml

15.4

7.5

1.11

142

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

410

1.52

3.10

1.4

57.3

62.7

0.69

337

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

410

1.52

3.10

1.5

1.6

ug/l

0.4

0.11

293

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

102

2.09

3.07

8.4

8.7

e6/l

722.5

261.2

0.43

(3006462) Nitrate [Presence] in Urine

167

994

1.33

3.06

3.0

2.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

192

1.77

3.03

1.0

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

3.15

3.02

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

202

1237

1.29

3.02

1.3

mmol/l

6.4

6.2

0.37

181

1150

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

246

1.67

3.00

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

183

1107

1.30

3.00

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1020

0.69

2.98

3.4

3.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

155

917

1.33

2.97

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1019

0.70

2.97

6.9

6.3

—

(44806071)

339

1.56

2.96

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

220

1366

1.27

2.96

1.9

2.0

g/24h

0.8

1.0

0.21

107

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

415

1.50

2.95

1.1

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

454

1.48

2.94

2.7

1.8

e6/l

4697.1

15129.5

1.21

232

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

315

1.58

2.93

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.19

2.93

1.0

u/ml

0.1

0.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

272

1739

1.23

2.85

2.6

2.1

—

(4211845)

180

1096

1.30

2.83

2.9

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

237

1494

1.25

2.82

2.0

2.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

583

1.41

2.80

1.5

1.7

iu/ml

—

423.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1371

9881

1.10

2.79

1.5

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.13

2.79

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

107

604

1.40

2.78

1.8

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

260

1660

1.24

2.77

1.4

e6/l

76504.2

87515.4

0.13

189

1120

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

309

2009

1.21

2.77

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.05

2.76

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

132

773

1.35

2.74

2.2

2.0

ug/min

71.2

106.5

0.32

173

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

699

1.37

2.74

2.0

1.7

u/ml

102452.5

27724.0

0.32

(3028308) Erythrocytes [#/volume] in Pleural fluid

204

1269

1.27

2.73

1.5

1.4

e6/l

38856.0

49478.9

0.37

140

727

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

193

1.72

2.72

1.1

u/ml

9.7

33.8

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

193

1.72

2.72

1.1

u/ml

25.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.87

2.62

3.3

4.2

—

(3004451) EKG impression Narrative

116

675

1.36

2.54

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

271

1.57

2.53

1.6

—

(3000285) Sodium [Moles/volume] in Blood

199

1.66

2.47

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

146

884

1.30

2.45

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

195

1225

1.26

2.45

3.6

3.2

mg/l

7.8

8.4

0.72

162

988

(3041672) Baker's yeast Ab [Presence] in Serum

152

1.76

2.45

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.02

2.44

1.0

1.2

u/field

1.4

1.2

0.36

(3027570) Oxalate [Moles/time] in 24 hour Urine

141

1.79

2.42

2.0

1.5

umol/24h

307.7

317.9

0.12

141

(3000012) Reticulocyte production index

135

811

1.31

2.41

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

219

1.62

2.40

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

169

1047

1.27

2.39

1.3

u/l

711.9

405.6

1.13

159

1003

(3032641) Amino acids panel - Urine

3.03

2.39

1.5

1.3

—

(3035880) pH of Pleural fluid

107

623

1.35

2.36

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

385

1.45

2.35

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.45

2.33

4.2

6.0

mg/l

1.1

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

120

1.84

2.32

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

525

1.38

2.30

1.5

1.4

55.6

50.3

0.60

449

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2288

16972

1.07

2.30

3.2

4.1

ug/l

13.4

23.6

2.01

1775

13040

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

648

1.34

2.27

4.5

4.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

219

1408

1.23

2.26

2.0

1.8

u/field

2.1

2.0

0.06

118

652

(3006567) Chloride [Moles/time] in 24 hour Urine

2.92

2.26

1.1

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

357

1.46

2.23

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

241

1569

1.21

2.21

1.4

g/l

34.2

34.4

0.09

220

1442

(3045177) Copper [Moles/volume] in Urine

2.71

2.20

1.0

1.1

umol/l

0.2

0.5

—

(3022229) Phosphate [Moles/volume] in Urine

140

1.75

2.19

1.6

2.4

mmol/l

20.6

20.8

0.01

122

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

194

1.63

2.19

2.3

2.1

u/field

0.6

0.7

0.17

194

(40768795) Lymph node Pathology biopsy report

215

2062

0.82

2.18

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

5.63

2.14

1.0

—

(3042733) HLA Ab [Presence] in Serum

136

834

1.29

2.13

4.3

5.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

303

1.48

2.11

2.1

2.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.32

2.10

1.5

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

515

1.36

2.08

2.7

1.9

e6/l

514.5

3840.9

1.13

344

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

495

1.37

2.08

1.5

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

172

1089

1.25

2.08

2.6

3.0

—

(3004775) Volume in Urine collected for unspecified duration

200

1291

1.22

2.03

2.3

2.4

660.5

661.9

0.02

153

942

(3036312) Salmon IgE Ab [Units/volume] in Serum

174

1.63

2.02

1.1

u/ml

0.7

1.2

0.36

119

(3018133) Calcium [Moles/volume] in Urine

385

1.41

2.01

1.8

2.3

mmol/l

2.3

2.7

0.80

348

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

302

2028

1.18

2.00

1.9

—

(3022689) Creatine [Moles/volume] in Urine

554

1.34

1.98

1.4

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

488

1.36

1.94

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

488

1.36

1.94

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

488

1.36

1.94

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

488

1.36

1.94

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

152

1.66

1.93

1.4

1.2

ml/s/173m2

1.4

1.9

0.39

104

(3007916) DNA double strand Ab [Titer] in Serum

297

1.46

1.92

1.4

titre

112.3

159.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

1.90

0.0

1.2

—

(40768446) Kidney Pathology biopsy report

147

926

1.25

1.89

2.0

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

247

1.50

1.87

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

451

1.36

1.87

1.1

u/ml

—

13.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.11

1.84

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

179

1.59

1.83

1.0

u/ml

24.3

19.1

0.21

150

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

638

1.30

1.81

2.1

1.9

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.63

1.79

1.2

1.3

umol/l

1006.0

2741.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

336

1.41

1.75

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

169

1.59

1.74

1.2

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.74

1.73

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.74

1.73

1.0

—

(3024316) Viscosity of Plasma

1.77

1.68

1.8

1.6

mpas

1.6

1.5

0.13

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.89

1.68

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

128

1.66

1.67

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

189

1242

1.20

1.67

1.6

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

176

1667

0.83

1.66

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

154

993

1.22

1.65

1.7

1.6

mmol/24h

5.3

5.7

0.18

101

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.94

1.60

1.1

1.2

u/field

2.5

1.0

0.42

(44806420)

329

1.39

1.60

1.8

2.3

—

(3017704) Immunofixation for Urine

119

749

1.25

1.59

1.4

1.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

136

1.62

1.59

1.3

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

303

1.41

1.59

1.4

g/l

27.5

27.2

0.03

241

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

259

1757

1.16

1.59

1.6

32.4

35.3

0.58

160

1094

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.09

1.58

5.7

8.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4535

34610

1.04

1.53

1.5

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

138

1.60

1.52

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

182

1.52

2.4

2.8

22.6

7.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.53

1.51

1.1

mmol/24h

155.3

136.8

—

(40765096) Chromosome analysis panel by Banding

500

0.71

1.50

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.63

1.49

1.3

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

283

1944

1.15

1.49

1.1

1.0

u/ml

3.7

4.3

0.09

453

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.97

1.47

1.1

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.76

1.45

1.3

1.2

ug/l

112.8

91.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

134

1.59

1.44

1.2

1.3

28.9

23.2

0.33

103

(4094501)

763

5552

1.09

1.42

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

291

1.38

1.40

1.1

pmol/l

2.0

4.1

1.29

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

161

1.52

1.37

1.2

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

360

1.34

1.36

2.6

5.1

u/l

54.2

62.7

0.18

145

(3001686) Cold agglutinin [Titer] in Serum or Plasma

354

1.34

1.35

1.1

1.3

titre

19.3

149.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

152

1003

1.20

1.34

28.4

26.8

ug/l

136.5

119.8

0.65

120

830

(3041184) Isoniazid [Presence] in Urine

2.63

1.34

2.0

2.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

218

1486

1.16

1.31

1.5

1.4

mmol/l

5.6

5.4

1.33

211

1410

(3019768) Coxiella burnetii Ab [Presence] in Serum

125

1.58

1.31

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.43

1.31

1.0

—

(36303858) Crystals [Presence] in Urine

2.43

1.31

1.3

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.13

1.28

1.1

2.0

2.9

—

(3033799) Differential panel - Peritoneal fluid

448

1.29

1.26

2.1

1.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

171

1.48

1.26

3.7

2.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

259

1794

1.14

1.26

1.1

1.0

u/ml

0.6

0.9

0.28

218

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1138

9521

0.94

1.26

1.8

—

(3019174) dRVVT (LA screen)

244

1.39

1.24

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

346

1.32

1.23

1.8

1.4

—

(3024932) HLA-DR beta [Type]

125

819

1.20

1.22

1.1

—

(3049233) Organic acids panel - Urine

2.17

1.20

1.1

1.0

—

(3024471) HLA-A [Type]

127

835

1.20

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

178

1206

1.16

1.19

2.2

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.97

1.18

1.0

1.1

nmol/24h

110.6

99.0

0.12

(3044007) Cell count panel - Peritoneal fluid

425

1.28

1.18

2.7

1.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

149

1.48

1.15

1.1

u/l

27.6

23.4

0.31

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

128

847

1.19

1.14

1.2

1.3

u/l

14.0

14.8

0.19

115

788

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

124

1.53

1.12

1.1

1.2

19.8

19.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.59

1.12

1.1

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

349

1.29

1.05

1.3

1.4

3.4

2.8

0.18

294

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

950

7933

0.94

1.04

1.4

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

114

755

1.19

1.04

3.0

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

127

1.49

1.03

1.1

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

121

1.50

1.01

1.4

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

154

1051

1.16

0.99

2.3

2.0

mg/l

8.7

9.5

0.87

124

841

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.98

0.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

827

0.83

0.97

1.9

2.0

ug/l

2.6

3.5

1.23

732

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

496

1.22

0.95

1.8

u/l

48.3

28.1

0.45

445

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

137

0.58

0.94

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

518

1.22

0.94

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.25

0.94

1.0

—

(3014891) Appearance of Pleural fluid

137

1.44

0.92

2.2

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

118

1.47

0.90

1.3

mmol/l

21.6

0.01

(3022670) pH of Venous cord blood

1.77

0.90

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

337

1.26

0.89

4.8

5.1

ug/min

31.0

42.6

0.94

257

(46235168) Fasting glucose [Moles/volume] in Blood

338

0.75

0.88

1.8

1.2

mmol/l

6.6

7.1

0.25

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

166

1.38

0.86

3.3

2.8

pmol/l

15.5

60.4

—

(3006598) pH of Arterial cord blood

1.69

0.85

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

233

1653

1.11

0.85

1.9

2.1

ug/l

28.3

23.8

0.33

227

1631

(3027456) Digoxin [Moles/volume] in Serum or Plasma

280

2006

1.10

0.85

3.2

3.0

nmol/l

0.8

0.48

203

1526

(3026692) Albumin [Mass/volume] in Peritoneal fluid

361

1.25

0.84

2.0

1.3

g/l

12.0

14.3

0.67

285

(3034092) Cytoplasmic Ig cells/100 cells in Blood

347

1.25

0.84

12.7

4.8

—

(4281824)

267

2316

0.91

0.84

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

205

1446

1.12

0.84

6.4

6.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

208

1.33

0.83

1.0

u/ml

0.2

1.1

0.65

(3025577) Chromium [Mass/volume] in Blood

803

0.84

0.83

2.0

2.1

ug/l

1.9

2.4

1.42

680

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

370

3156

0.92

0.81

1.7

1.6

mmol/l

7.8

7.4

1.71

239

1846

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.80

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.80

0.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.80

14.1

9.2

—

(3025315) Body weight

169

1.35

0.79

4.6

3.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

294

1.26

0.78

2.6

2.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

310

1.25

0.75

4.1

2.9

—

(3022475) Manganese [Moles/volume] in Blood

157

1.36

0.75

1.1

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

122

841

1.14

0.74

1.9

1.7

au/ml

107.6

125.9

0.19

107

(3029612) Listeria sp Ab [Titer] in Serum

1.58

0.74

1.8

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

104

1.44

0.73

3.6

3.2

—

(40768806) Pleura Pathology biopsy report

178

1258

1.12

0.73

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

415

0.80

0.73

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.60

0.73

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.97

0.71

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

299

0.76

0.71

1.2

1.3

ug/l

29.7

323.8

2.62

168

(3018834) Bilirubin.total [Presence] in Urine by Test strip

116

0.61

0.70

2.7

3.0

—

0.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

187

1.31

0.70

1.3

1.4

7.8

14.4

1.21

104

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.58

0.69

1.1

1.2

u/field

1.4

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.47

0.68

1.0

u/ml

0.0

0.2

0.79

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.57

0.68

1.0

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.54

0.68

2.8

2.5

nmol/l

33.0

23.9

—

(3003577) Lead [Moles/volume] in Blood

225

0.74

0.68

1.2

1.5

umol/l

0.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

421

3542

0.94

0.67

3.4

3.5

u/ml

25.1

36.4

2.06

398

3407

(3027035) Albumin [Mass/time] in 24 hour Urine

190

1.29

0.64

1.2

1.3

mg/24h

245.6

321.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

368

1.20

0.63

1.8

2.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

470

1.17

0.63

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

589

1.15

0.61

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

211

1524

1.09

0.61

2.1

1.8

—

(3020650) Glucose [Presence] in Urine

735

0.87

0.60

1.6

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

116

1.36

0.59

5.4

4.8

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

271

1.22

0.58

2.8

2.9

pmol/l

74.3

69.0

0.06

235

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

435

3236

1.06

0.58

2.8

3.7

u/ml

564.2

779.9

0.27

389

2948

(3051387) C reactive protein [Mass/volume] in Capillary blood

582

4366

1.05

0.57

4.5

2.9

mg/l

22.5

25.5

1.11

360

2702

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.69

0.57

2.7

2.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.40

0.56

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.55

0.56

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

132

937

1.11

0.55

1.5

3.3

4.4

0.26

218

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

311

0.81

0.53

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

627

1.13

0.52

1.8

2.6

ng/l

114.1

110.6

0.08

354

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

175

1503

0.92

0.52

1.3

1.2

—

(3013466) aPTT in Blood by Coagulation assay

175

1.26

0.52

1.1

34.9

35.9

0.55

144

(3032352) Blasts [#/volume] in Cerebral spinal fluid

204

1.24

0.51

2.3

2.7

—

(3009871) Measles virus Ab [Titer] in Serum

107

939

0.90

0.50

1.7

1.6

—

(4038314)

291

0.81

0.50

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.47

0.49

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.58

0.49

1.1

—

(3012565) Volume of 24 hour Urine

139

998

1.10

0.49

1.8

2.2

2039.7

2054.5

0.04

125

916

(3015183) Erythrocyte sedimentation rate

181

1545

0.92

0.48

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

483

1.14

0.48

1.3

1.2

g/l

40.4

40.0

0.13

266

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.43

0.48

1.3

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

122

0.71

0.47

1.0

u/ml

0.4

0.2

—

(4133840)

751

0.89

0.46

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.45

0.46

1.6

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

317

2361

1.06

0.45

1.5

1.6

51.4

53.3

0.33

189

1522

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

288

1.18

0.44

1.1

1.0

—

(3034614) HLA Ag [Interpretation]

1.42

0.43

1.5

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

242

0.81

0.42

2.5

3.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.58

0.42

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.58

0.42

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.58

0.42

1.8

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.58

0.42

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.58

0.42

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.58

0.42

2.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

258

0.82

0.41

3.9

5.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

167

1.23

0.41

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

834

0.91

0.40

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

289

2156

1.06

0.40

1.4

1.3

pmol/l

77.7

132.9

0.64

110

617

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.35

0.39

1.1

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

111

1.28

0.39

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

111

1.28

0.39

1.1

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.36

0.38

1.3

1.6

mmol/24h

2.4

2.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.41

0.38

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1281

10340

0.98

0.37

1.5

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

406

1.13

0.36

1.2

mg/l

78.7

60.9

0.08

287

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

354

1.14

0.36

1.4

—

(4212803)

127

1.24

0.36

1.2

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

200

1.18

0.35

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.33

0.34

1.0

—

(3045142) Bone marrow Pathology biopsy report

224

1864

0.95

0.33

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

150

1.21

0.33

1.0

1.1

u/ml

0.3

10.3

0.51

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.31

0.33

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.30

0.32

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

682

1.09

0.31

1.8

1.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

144

1.20

0.31

1.0

—

(3048879) Bone marrow aspiration report

411

1.11

0.31

2.1

2.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

102

1.24

0.29

2.3

1.8

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.29

0.28

1.0

1.3

—

(3013862) HLA-DP [Type]

102

0.77

0.28

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.24

0.27

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.21

0.27

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

287

0.88

0.26

2.5

2.7

u/l

2459.3

1920.7

0.18

261

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

200

1.14

0.24

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

100

0.79

0.24

1.0

—

(46236302) HLA-C [Type] by High resolution typing

100

0.79

0.24

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

335

1.11

0.24

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.31

0.23

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.31

0.23

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

127

1.18

0.23

2.8

4.9

—

(40760410) HLA-B [Type] by High resolution

0.80

0.23

1.0

—

(40760409) HLA-A [Type] by High resolution

0.80

0.23

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

275

0.89

0.23

8.4

9.1

umol/l

0.3

0.4

0.18

256

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.27

0.23

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

423

0.91

0.22

1.3

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

195

1.13

0.21

1.1

1.2

mmol/l

2.7

1.6

0.28

134

(4035726)

2182

17006

1.01

0.21

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

218

1.12

0.21

1.1

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.28

0.20

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

289

0.90

0.20

7.1

7.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

107

1.18

0.20

3.9

5.9

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

105

0.83

0.19

1.0

u/ml

0.1

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

167

1.13

0.19

1.0

1.1

u/ml

0.8

12.3

0.48

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.17

0.18

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

117

966

0.95

0.17

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

392

0.92

0.17

14.4

8.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

381

1.08

0.17

2.4

2.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

229

1.10

0.17

1.2

mmol/l

1.8

1.9

0.21

140

(40768793) Breast Pathology biopsy report

666

5159

1.02

0.17

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

376

2896

1.02

0.16

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

128

0.86

0.16

3.5

2.3

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.11

0.16

2.1

1.4

mg/l

16.2

5.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

337

1.08

0.15

1.8

1.7

mg/l

1.6

1.7

0.30

285

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

217

0.91

0.14

3.3

3.1

mg/l

1.2

0.02

126

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

562

1.05

0.14

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

194

1.10

0.14

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

563

1.05

0.13

1.3

1.1

—

(40762814) Titanium [Mass/volume] in Blood

224

0.91

0.13

2.0

2.4

ug/l

3.4

3.7

—

(40758358) Immune stain study

0.82

0.13

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

564

1.05

0.13

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

295

1.07

0.12

1.1

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

288

0.93

0.12

1.4

30.3

24.3

0.45

244

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

433

0.95

0.12

14.1

8.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

113

861

1.03

0.11

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

258

1.07

0.11

1.7

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

182

1.08

0.10

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

131

1004

1.03

0.10

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

106

1.12

0.10

1.0

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.09

0.09

1.0

umol/l

424.8

391.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.09

0.09

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.07

0.08

2.7

2.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.08

0.08

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

717

5605

1.01

0.07

1.9

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

186

1441

1.02

0.07

2.0

1.8

mg/l

3.4

0.01

170

1381

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

494

3930

0.99

0.06

1.4

mmol/l

7.1

6.8

1.18

361

2827

(3002523) Influenza virus A Ag [Presence] in Specimen

664

5194

1.01

0.06

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.10

0.05

1.3

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.11

0.05

4.4

3.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

119

0.93

0.05

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

446

0.97

0.05

1.6

1.8

ug/l

1.5

3.8

1.22

274

(3003740) Influenza virus B Ag [Presence] in Specimen

663

5196

1.01

0.04

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

157

1.05

0.04

1.2

u/l

29.5

280.6

0.73

116

(3001729) Color of Synovial fluid

134

0.94

0.04

1.8

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

331

2592

1.01

0.03

1.5

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

166

1.04

0.03

1.2

1.3

mmol/l

5.6

5.9

0.09

(21494434) Karyotype in Bone marrow

173

1373

0.99

0.02

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

482

1.01

0.01

1.1

1.4

39.4

42.5

0.22

330

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.94

0.01

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

507

1.01

0.00

1.3

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

161

1.03

0.00

1.4

1.5

ug/l

92.2

113.7

0.58

138

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

132

1.02

0.00

2.1

1.8

40.6

63.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

106

0.97

0.00

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

138

0.97

0.00

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.03

0.00

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.95

0.00

2.7

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.04

0.00

1.7

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

264

0.99

0.00

1.9

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

104

0.99

0.00

2.1

1.8

5.8

17.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.96

0.00

37.3

12.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.01

0.00

5.6

5.1

mmol/l

0.2

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.6

—

4.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.5

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

6.3

—

(3025311) HLA-B [Type]

0.00

0.0

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

608.2

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.2

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PULM_ANXIETY – Anxiety (asthma-related co-morbidities)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Anxiety (asthma-related co-morbidities)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Anxiety (asthma-related co-morbidities) (PULM_ANXIETY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints